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ABSTRACT 
 
KaiC CII Ring Flexibility Governs the Rhythm of the Circadian Clock of Cyanobacteria. 
 (May 2011) 
Nai-Wei Kuo, B.S.; M.S., National Tsing Hua University, Taiwan 
Co-Chairs of Advisory Committee: Dr. Andy LiWang,  
                                                   Dr. Pingwei Li 
 
    The circadian clock orchestrates metabolism and cell division and imposes important 
consequences to health and diseases, such as obesity, diabetes, and cancer. It is well 
established that phosphorylation-dependent circadian rhythms are the result of circadian 
clock protein interactions, which regulate many intercellular processes according to time 
of day. The phosphorylation-dependent circadian rhythm undergoes a succession of 
phases: Phosphorylation Phase → Transition Phase → Dephosphorylation Phase. Each 
phase induces the next phase. However, the mechanism of each phase and how the 
phosphorylation and dephosphorylation phases are prevented from interfering with each 
other remain elusive. In this research, we used a newly developed isotopic labeling 
strategy in combination with a new type of nuclear magnetic resornance (NMR) 
experiment to obtain the structural and dynamic information of the cyanobacterial 
KaiABC oscillator system. This system is uniquely suited for the mechanistic studies: 
mixing KaiA, KaiB KaiC, and ATP generates a self-sustained ~24 h rhythm of KaiC 
phosphorylation in vitro. Our data strongly suggest that the dynamic states of KaiC 
underpin the timing mechanism of cyanobacterial oscillator.  
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CHAPTER I  
INTRODUCTION 
 
1.1 Central Oscillator 
 
Endogenous circadian clocks have been found in diverse organisms, including 
prokaryotes, and eukaryotes ranging from cyanobacteria (1), fungi (2), plants (3), insects 
(4), to humans (5). The coordination of physiological activities and behavior of diverse 
organisms to the external environment by the circadian clock is crucial to reproductive 
fitness, as demonstrated by cyanobacteria (6), flies (7), and plants (8).  
All circadian clocks fulfill three criteria: 
1. The ~24 h rhythm is self-sustained under constant environmental conditions (9).  
2. The phase of the clock can be reset by external cues, such as light (10).  
3. The rhythm is temperature compensated (11). It means the period of the circadian 
rhythm changes less with temperature variation than most enzymatic reactions. 
All circadian clocks include the following three components: 
1. Input pathway is to synchronize biological time to external cues.  
2. Central oscillator is to generate a ~24 h rhythm and maintain internal time.  
3. Output pathway is to transmit the rhythm downstream to clock-controlled effectors.       
    Environmental cues, such as daylight, are transduced to the central oscillator through 
input pathways. They induce a phase shift in the rhythm generated by the oscillator, the 
magnitude of which depends on the phase position of the signal. Output pathways 
transduce the biochemical rhythm generated by the oscillator into rhythmic expression of 
clock-controlled genes. Central to the circadian rhythm is at least one oscillator with 
positive and negative elements that form feedback loops (12). Up to now, genetic and 
_____________ 
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biochemical studies have helped identify the components of central oscillators in diverse 
organisms.   
    In mammals, the circadian clock has long been associated with health and disease 
problems, such as obesity (13), diabetes (14), and cancer (15). To date, eight core 
circadian clock genes have been found in mammals. They are Casein kinase 1ε (CK1ε); 
Cryptochrome1 (Cry1) and Chryptochrome2 (Cry2); Period1 (Per1), Period2 (Per2), 
and Period3 (Per3); Clock (Clk), and Bmal1. The molecular clocks in peripheral tissues 
are associated with metabolism (13) and cell growth (16). For example, Clock mutant 
mice gain more weight upon aging than normal mice, especially in fat mass over a 10 
week period (13). In general, Clock mutant mice fed either regular or high-fat diet 
showed an increase in energy intake and body weight. Comparison of somatic growth 
and solid organ mass revealed no difference. However, the body weight gain on Clock 
mutant mice fed a regular diet was attributed to 65% of lean mass and 35% of fat mass, 
whereas 25% lean mass and 75% of fat mass for the mutant mice fed a high-fat diet 
relative to wild-type mice. At an age of 6-7 months, Clock mutant mice developed 
hypercholesterolemia, hypertriglyceridemia, hyperglycemia, and hypoinsulinemia. The 
aberrant metabolic changes and endocrine hormones secretion were caused by 
dysfunctional clock gene expression (13).  
Prompted by the evidence that the circadian clock affects the metabolism through 
cellular processes, Marcheva et al. tried to dissect the impact of clock function within the 
pancreatic islets (14). They found that disruption of Clk and Bmal1 induce 
hypoinsulinaemia and diabetes. The pancreatic islets secrete insulin to maintain glucose 
homeostasis during the feeding period, and dysfunctional insulin release is linked with 
diabetes (17). The self-sustained circadian rhythms of gene expression of the 
transcription factors Clk and Bma11 were found to exist in the pancreatic islets. β-cells 
are a type of cell in the pancreas and its function is to make and release insulin to control 
the level of glucose in blood. A mutation in the Clock gene disrupted the generation of 
Clk and Bmal1 and leading to impaired glucose tolerance, reduced insulin secretion, and 
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progressive β-cell failure (14). The results showed that ablation of the pancreatic clock 
can trigger diabetes mellitus.  
Furthermore, Per1 and Per2, two clock genes in mice, suppressed tumor growth (16, 
19); knockdown of a clock-related gene, CK1ε, inhibited the growth of cancer cells (20). 
Both mPer1 and mPer2 function in tumor suppression by regulating the transcription of 
the clock-controlled genes, which sensitized cancer cells to radiation-induced apoptosis 
(16, 19). Furthermore, hPer1 may have direct interactions with a cell-cycle checkpoint 
pathway (19). Knocking down CK1ε, inhibited growth of engineered tumor cells more 
than in normal cells. Thus, tumor cells are more sensitive than normal cells to the kinase 
activity of CK1ε. The use of specific kinase inhibitors to CK1ε revealed that Per2 is a 
substrate of CK1ε and also modulates growth inhibition of tumor cells (20).   
 
Figure 1 The common elements in a circadian loop. In mammals, positive elements are 
Clk aad Bmal1; in Drosophila, positive elements are Clk and Cyc; in Neurospora, 
positive elements are WC1 and WC2. Negative Elements are Per1-3 and Cry in mamals; 
Per, and Tim in Drosophila; FRQ in Neurospora. In cyanobacteria, positive element is 
KaiA and negative elements are KaiB and KaiC. This figure is adopted from (18). 
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The central oscillators of most model organisms apparently follow the transcription 
translation feedback loop (TTFL) model. Fig. 1 is a simple example of transcription-
translation feedback loop (18). The positive elements activate the transcription of the 
clock genes encoded negative elements; meanwhile, downstream gene expression is also 
activated by the positive elements. The negative elements inhibit the function of the 
positive elements. After the degradation of the negative elements in eukaryotes (or 
dephosphorylation of negative elements in cyanobacteria), the positive elements are 
derepressed to allow the whole cycle to start anew. In addition to the transcription-
translation feedback loop, central oscillators are regulated by post-translational 
modifications (PTMs), mainly through phosphorylation. Phosphorylation is used to 
control protein localization, degradation, and the activity of proteins. Phosphorylation 
exerts its effect by remodeling the protein structure. As we will show here, 
phosphorylation can also be used to regulate protein flexibility.  
Phosphorylation plays a major role in the circadian clock system. Take the Per/Tim 
feedback loop of Drosophila melanogaster as a example (Fig. 2) (21). The positive 
elements clock (Clk) and cycle (Cyc) form a heterodimer to bind to an E-box from mid 
day through early night. This Clk/Cyc heterodimer activates the transcription of Period 
(Per) and Timeless (Tim), which are negative elements and form a heterodimer to inhibit 
the transcription of Clk and Cyc. The Per and Tim mRNA levels reach a maximum in the 
night, whereas Per and Tim proteins do not reach maximal levels until late evening, due 
to the phosphorylation-dependent destabilization of Per by Dbt and possibly by CK2. 
Dbt and CK2 phosphorylate Per leading to degradation, whereas, PP2a can stabilize Per 
by removing the phosphate group (21). Tim also stabilizes phosphorylated Per in a 
Tim:Per:Dbt complex. This complex is transported to nuclei after Tim is phosphorylated 
by Sgg, which occurs in the subjective night. This complex then binds to Clk/Cyc, and 
the Per/Tim/Clk/Cyc complex then disengages the E-box to stop transcription of Per and 
Tim by subjective night. Per and Clk are subsequently degraded because of Dbt-induced 
phosphorylation. Tim is degraded upon phosphorylation at a tyrosine residue at 
subjective dawn. After one circadian cycle, the newly-formed Clk/Cyc heterodimer will 
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activate the transcription of Per and Tim to start another cycle. A central feature of the 
timing mechanism is that phosphorylation of positive and negative elements regulate the 
delay between activation and repression of transcription to maintain the ~24 h cycle (22).  
It has been demonstrated that perturbation of phosphorylation of clock proteins can 
profoundly affect circadian rhythms. For example, the tau hamster, which has a short 
free-running period (20 hr), has a mutation in casein kinase Iε  (CKIε) protein (23), 
which normally phosphorylates Per2. CKIε[tau] reduces the kinase activity on the 
phosphorylation sites of Per2 that stabilize Per2, whereas phosphorylation sites that 
destabilize Per2 are not affected or less affected by CKIε[tau]. The uneven influence on 
the different phosphorylation sites may lead to the premature clearance of nuclear Per2  
 
Figure 2 Model of Per/Tim feedback loop. Black line with arrow, sequential steps in 
the transcription-translation feedback loop; block line, inhibition; dashed line with 
arrow, protein degradation; P, protein phosphorylation. The figure is adopted from 
(21). 
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resulting in the short period (24). Moreover, mutation of a CKIε phosphorylation site in 
human Per2 (Ser662 to Gly) decreases Per2 phosphorylation in vitro (25). This T44A 
mutation of hCKIε decreases its kinase activity on Per2/3 in vitro (26). Both mutations 
have been identified as the causes for Familial Advance Sleep-Phase Syndrome (FASPS) 
(25-27). The V647G mutation in human Per3, linked to Delayed Sleep-Phase Syndrome 
(DSPS), is speculated to alter its CKIε dependent phosphorylation (28). The 
hCKIε S408Ν mutant, which is commonly found in DSPS individuals, increases its 
kinase activity by 1.8 fold in vitro (29). Although higher organisms have multiple 
oscillators, more complex TTFLs and PTMs, the basic mechanisms essential for a clock 
are similar between diverse organisms. For example, in cyanobacteria, at least one 
oscillator, one transcription-translation feedback loop, and phosphorylation are involved 
in regulating the clock. Therefore, the timing mechanism of the simple cyanobacterial 
clock will lead to new insights into the complex clocks of eukaryotes. 
   Among prokaryotes and eukaryotes, the clock systems of the latter have more complex 
networks of transcription-translation feedback loops (TTFLs) and post-translational 
modifications (PTMs). In addition to phosphorylation, mammalian circadian systems 
have additional PTMs such as acetylation and SUMOylation (30, 31). The Clk/Bmal1 
complex activates transcription by acetylation of histone proteins (32, 33). Clk itself is 
an intrinsic histone acetyltransferase (HAT) (31). Bmal1 enhances Clk HAT activity 
probably through large conformational changes on Clk. The Clk/Bmal1 heterodimer 
activates Per transcription. However, without acetylation at the Per1 promoter by Clk, 
Clk/Bmal1 fails to activate transcription (31). On the other hand, Sumoylation of Bmal1 
is induced by Clk (30). Sumoylation affects proteosomal degradation of Bmal1 and also 
the stability of the Clk/Bmal1 heterodimer (34). In contrast to mammalian systems, in 
Drosophila and Neurospora, the only PTM involved in clock regulation is 
phosphorylation (22). All eukaryotic clock function apparently requires translocation of 
clock proteins between the cytoplasm and nucleus. These complexities associated with 
eukaryotic clocks make them difficult systems for mechanistic studies, as their 
oscillators cannot be separated from the complex milieu of the cell. 
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However, the TTFL paradigm for eukaryotic circadian oscillators may be in danger. 
Recently, robust, temperature compensated circadian rhythms were observed in human 
red blood cells (RBCs) (35). A novel post-translational biomarker, peroxiredoxin 
oxidation, was used to confirm the rhythmicity. Red blood cells have no nucleus (or 
DNA) and thus cannot have a transcription-translation feedback loop. The 
peroxiredoxins undergo a circadian rhythm in sensing the redox state in RBCs (35). 
These rhythms must be driven by a non-transcriptional oscillator. This observation is the 
first one showing that the transcription is not required for self-sustained circadian 
oscillations in human cells. Peroxiredoxins (PRXs) are a highly conserved family of 
antioxidant proteins that control the peroxide level in cells (36). They share a common 
catalytic mechanism  in which the Cys residues in the active site are oxided to sulphenic 
acid by a peroxide substrate, forming a disulfide bond which is subsequently reduced by 
thioredoxin to complete one catalytic cycle (36). The dimeric form of PRX was found to 
be regulated by the redox state in the cell. Therefore, the mechanism of rhythmic PRX-
SO2/3 formation were explored. RBCs were found to have circadian rhythms of PRX 
dimerization, hemoglobin tetramer-dimer transitions, and NADH/NADPH ratios (35). 
Peroxiredoxins dimer formation and NADH/NADPH oscillations were also present in 
nucleated cells. In Cry1 Cry2 knock down cells, PRX-SO2/3 rhythms persisted, although 
with longer free-running periods. It indicates that a TTFL probably influences the PRX-
SO2/3 rhythm. Thus, their finding reveals an interrelationship between TTFLs and PTMs 
in regulating the circadian rhythm. Overall, it is similar with the model in cyanobacteria 
where the central oscillator is controlled by both PTM and TTFL. However, the central 
oscillator of cyanobacteria can be regulated by PTM in vitro. Thus, elucidating the 
mechanism of the KaiABC oscillator will provide important insights into the clocks of 
eukaryotes. 
    Cyanobacteria, unicellular photosynthetic prokaryotes, have the simplest known 
circadian clocks. The most extensively characterized cyanobacterial clock is that of 
Synechococcus elongatus (12, 37). Like all other circadian systems, this one clock has 
input and output pathways and a central oscillator. There are three well-characterized 
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components of the clock-input pathway: LdpA (light-dependent period) (38), Pex 
(period extender) (39), and CikA (circadian input kinase) (40). Light flux affects the 
cellular redox state through photosynthesis. There is a light-dependent reductive state for 
growth, and a dark oxidative mode for cell maintenance. LdpA provides a link between 
light intensity and period length by sensing the redox state of the cell through its iron-
sulfur clusters (41) (Fig. 3a). S. elongatus mutants that lack the ldpA gene no longer 
follow Aschoff’s rule and have free-running periods that are consistent with higher light 
intensities. Pex plays a role in slowing down the clock (42), probably by repressing 
expression of kaiA by directly binding to its promoter (43). CikA, like LdpA, connects 
the redox state of the cell with the phase of the circadian rhythm (44). This connection 
appears to be achieved through direct interactions between quinones and the pseudo-
receiver domain of CikA (44, 45) (rather than through iron-sulfur clusters). Indeed, in 
the absence of CikA, S. elongatus mutants do not reset the phase of their circadian 
rhythm in response to dark pulses (46).  
    All genes in S. elongatus are under clock control (46) which means that clock output 
pathways likely exert genome-wide regulation over gene expression. Indeed, the genome 
undergoes daily Kai-dependent cycles of compaction and decompaction (47), which 
should affect rhythmic promoter accessibility (Fig. 3, c, d, and e). A key component of 
the global output pathway is the protein SasA. Inactivation of SasA abolishes rhythmic 
expression of all genes except for the kai genes (48, 49). However, in sasA-null strains 
chromosome compaction rhythms persist, which suggest that promoter accessibility is 
not sufficient for rhythmic gene expression and that SasA is required to transmit 
information from the central oscillator to the gene expression machinery (47). SasA is 
regulated by the central oscillator through direct interactions between its N-terminal 
domain and KaiC (48). This interaction induces rhythmic autophosphorylation of a 
conserved histidine residue in the C-terminal domain of SasA. SasA is a histidine protein 
kinase and part of a two-component signal transduction system (50). Upon 
autophosphorylation, SasA transfers the phosphate group to its cognate response 
regulator , RpaA (49). The phosphorylated form of the response regulator then  produces 
  9
 
Figure 3 The Synechococcus elongatus circadian clock system. It is schematically 
shown with interacting (a) input, (b) central oscillator, and (c-e) output components. 
(a) input pathway. External cue, such as light, is transmitted through Pex, LdpA, 
and CikA. The quantity of light changes the redox state of cell. LdpA is a redox 
active-ion-sulfur protein and CikA can sense the redox state and binds to a quinine 
molecule. Pex protein inhibits KaiA expression by direct binding to promoter region. 
In the absence of any of these three proteins leads to a shorter circadian rhythm. (b) 
The central oscillator contains three proteins: KaiA, KaiB, and KaiC. KaiA 
stimulates KaiC phosphorylation and KaiB inhibits KaiA function on KaiC 
phosphorylation activity. Deficiency at any of these three proteins abolishes the 
circadian rhythm. (c) SasA binds to N terminus of KaiC. The temporal information 
is transduced through by KaiC stimulates the autophosphorylation of SasA. 
Transfer of a phosphoryl group from SasA activates RpaA. LabA serves as a 
negative regulator modulated by KaiC to repress RpaA function. (d) KaiC oscillator 
regulates chromosome compaction rhythm and allows transcription machinery to 
bind to promoter regions. (e) SasA and RapA are not necessary for chromosome 
compaction but they are necessary for the rhythmic gene expression. The figure is 
adopted from (37). 
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an intracellular response, such as regulation of gene expression (50).    In fact, disruption 
of rpaA leads to the same arrhythmic transcription phenotype as sasA disruption. The 
SasA-RpaA regulatory system has been linked to ATPase activity from KaiC in 
controlling downstream cell division (51). The elevated ATPase of KaiC inhibits cell 
division through SasA-RpaA. Another output pathway protein, LabA, appears to mediate 
the repressive effects of KaiC on gene transcription (52): in the absence of LabA, KaiC 
no longer represses its own gene expression. 
The central oscillator of the cyanobacterium S. elongatus is composed of only three 
proteins, KaiA, KaiB, and KaiC (53). The phosphorylation rhythm of KaiC, regulated by 
KaiA and KaiB, correlates to the rhythms of gene expression (54). At first, this oscillator 
was thought to fit into the TTFL model (53). Indeed, the positive element KaiA 
enhances transcription of kaiB and kaiC from a common promoter, whereas KaiC, the 
negative element, attenuates kaiBC expression (53). Yet, early observations suggested 
that the Kai oscillator might not fit the TTFL paradigm. For example, driving expression 
of kaiBC either from a promoter from E. coli (55) or antiphase to its normal rhythm (56) 
did not disrupt circadian rhythmicity.  
Under constant darkness, S. elongatus, an obligate photoautotroph, ceases 
transcription and translation (57). Thus, if the S. elongatus clock follows the TTFL 
model, it should stop under constant darkness, violating a defining criterion that an 
autonomous circadian rhythm continues to be generated under constant conditions (LL 
or DD). The Kondo group therefore tested whether circadian rhythms of KaiC 
phosphorylation persist in S. elongatus under constant darkness (or under constant light 
in the presence of transcriptional or translational inhibitors) (57). Their observation of a 
robust rhythm of KaiC phosphorylation in the absence of transcriptional and 
translational activity demonstrated that the central oscillator generates a rhythm only 
through PTMs (57). Indeed, that same year, the Kondo group showed that a mixture of 
recombinant KaiA, KaiB, and KaiC proteins purified from E. coli and ATP generated a 
self-sustained and temperature-compensated rhythm of KaiC phosphorylation in a test 
tube for three days (58). Therefore, this cyanobacterial oscillator, the KaiABC system, 
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fully viable outside of the complex milieu of the cell, is the most suitable model system 
for in vitro biochemical and structural studies. Our goal here is to establish a 
comprehensive understanding of the timing mechanism of this simplest of oscillators. 
In S. elongatus the autonomous rhythm is generated by three proteins, KaiA, KaiB, 
and KaiC independent of transcriptional and translational processes (58). KaiC is an 
autokinase and an autophosphatase with two phosphorylation sites, S431 and T432 (54, 
59-61). In addition, KaiC has an ATPase activity (53, 62). Both in vivo and in vitro, 
KaiA stimulates KaiC autophosphorylation whereas KaiB by itself has no effect on KaiC 
phosphorylation, but functions by hindering KaiA function, leading to KaiC 
dephosphorylation (54, 60, 63, 64). Under rhythmic interactions with KaiA and KaiB, 
KaiC has four different phosphorylation states that are temporally ordered: ST → SpT 
→ pSpT→ pST→ ST (65, 66), where S and T and pS and pT are the unphosphorylated 
and phosphorylated forms of S431 and T432, respectively. Single mutants or double 
mutants at these two residues abolish the circadian rhythm, indicating the 
phosphorylation of these two residues is essential to the clock function (59). In vivo, the 
phosphorylated forms of KaiC are necessary to maintain circadian rhythms of 
downstream gene expression, but rhythms of KaiC phosphorylation are not (67, 68). 
Indeed, circadian rhythms of gene expression persist even when KaiC is constitutively 
phosphorylated (68). However, at low temperatures, rhythmic gene expression requires 
rhythmic KaiC phosphorylation (68). Thus, these results indicate that multiple pathways 
are important to maintain accurate and robust circadian rhythms in cyanobacteria in vivo 
(68). 
KaiA actively associates with KaiC and stimulates KaiC phosphorylation during the 
Phosphorylation Phase (54). Then, the high level of KaiC phosphorylation induces the 
association of KaiB with KaiC and their sequestration of KaiA in a KaiCB(A) complex. 
This complex induces the Dephosphorylation Phase of KaiC. When KaiC becomes 
hypophosphorylated, KaiB dissociates from KaiC, thereby reactivating KaiA (69). This 
model is consistent with the electron microscopy and native gel electrophoresis results 
(70). Both methods demonstrate that the KaiA:KaiC complex exists at each phase, 
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whereas KaiB:KaiC and KaiCB(A) complexes only exist during the Dephosphorylation 
Phase (70). Indeed, the four phosphoforms of KaiC, ST, SpT, pSpT, and pST, exist at 
different ratios at each phase (65, 66, 70). Therefore, temporal Kai protein-protein 
interactions are correlated with the KaiC phosphorylation cycle, which is characterized 
by the ratios of different phosphorylation states of KaiC.  
To understand the mechanism of KaiC phosphorylation, knowing the structures of the 
Kai proteins is important. Three-dimensional (3D) high resolution structures of KaiA(64, 
71, 74, 75), KaiB(72, 76, 77), and KaiC(73, 78)  have been solved by X-ray 
crystallography (Fig. 4). The potential binding sites among Kai proteins have been 
studied in molecular and structural detail as well. KaiC is a two-domain homohexamer 
sharing sequence similarities to the bacterial helicase RecA (Fig. 4) (73, 79). Two 
domains of KaiC form a doughnut–like shape with twelve ATP molecules bound at the 
interfaces of both CI (KaiC N-terminal) and CII (KaiC C-terminal) domains. KaiC has a 
molecular weight of about 360 kDa and a dimension of 100x100 Å (73, 80). Similar to 
helicases such as RecA, the CI domain, has a weak ATPase activity that oscillates in a 
 
Figure 4 The X-ray crystal structures of KaiA, KaiB, and KaiC. KaiA (PDB ID:1R8J) 
(71), KaiB (PDB ID: 1WWJ) (72), and KaiC (PDB ID: 1TF7) (73). KaiA, KaiB, and 
KaiC show as relative size. Each color indicates one subunit. KaiA is a domain-
swapped homodimer. KaiB is a homotetramer. KaiC is a homohexamer with two 
donut–like shape. ATP molecules in KaiC are shown as black spheres. 
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circadian manner with CII autokinase activity (62). Unlike RecA, KaiC has no helicase 
activity (81). KaiC phosphorylation sites are located in the CII domain (59, 60). CII 
domain has autokinase and autophosphatase activities (53, 54, 61, 62). The conformation 
of the CI and CII domains are similar but the ATP binding pockets at the CI and CII 
domains have significant differences (73). ATP molecules bind more tightly to the CI 
domain than the CII domain, enabling isolated CI domains to form stable hexamers (80). 
By comparison, ATP molecules bind weakly to the CII domains (80, 82, 83). Stabilizing 
interactions between CI residues and the ATP nucleobase moiety are not found between 
CII residues and adenine (73), which explains the differences in ATP affinities. The X-
ray crystal structure of KaiC showed that the distance between the hydroxyl group of 
T432 and S431 and the γ-phosphorus atom is 6.6 and 8.5 Å, respectively. However, 
according to an analysis by Mildvan (84), the upper distance limit for phosphoryl 
transfer between the phosphorus atom and acceptor oxygen is 5.0 Å, which helps explain 
why KaiC by itself dephosphorylates. This observation also implies that the KaiA:KaiC 
interaction somehow shortens the distance by at least 1.5 Å, thereby inducing 
phosphoryl transfer.  
   S. elongatus KaiA is a domain-swapped homodimer (Fig. 4), where the N-terminal 
domain of one subunit from residues 1 to 135, KaiAN, is packed against the C-terminal 
domain from residues 180 to 283, KaiAC, of the other subunit (71). KaiAN adopts the 
fold of receiver domains (64) but lacks the invariant phospho-accepting aspartate residue 
of authentic receivers (50). Thus, the structure of KaiAN is that of a pseudo-receiver 
domain, like the one in CikA (45). KaiAN has no effect on the phosphorylation activity 
of KaiC. It is KaiAC that has the stimulating activity for KaiC (64). Indeed, KaiAC forms 
a tight complex with the last thirty C-terminal residues of KaiC (85), which includes a 
segment that is found looped inside the X-ray structure of KaiC (73). Full-length KaiA 
enhances KaiC phosphorylation less than KaiAC does. Thus, KaiAN may attenuate the 
KaiA and KaiC interaction by affecting the structure KaiAC (86). Recent data from our 
laboratory suggests that KaiA activates KaiC phosphorylation by stabilizing this exposed 
“A-loop” (86). It is anticipated that displacement of the A-loop reduces the distance 
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between ATP and T432 by at least 1.5 Å. Phosphorylation is induced by the 
rearrangement of ATP, S431 and T432 side chains. For the Phosphorylation Phase, in 
spite of NMR and crystal structures, it is not known how KaiA binding to KaiC activates 
phosphorylation of KaiC at sites located 20 Å from the KaiA-KaiC binding site.  
KaiB hinders KaiA stimulation of KaiC in an unknown manner. The Transition Phase 
occurs when KaiB dimers form a stable complex with hyperphosphorylated KaiC. 
According to EM results (87), two KaiB dimers associate with one KaiC hexamer. Once 
KaiB binds to hyperphosphorylated KaiC, KaiA is recruited to the KaiB:KaiC complex, 
forming a KaiCB(A) complex in which KaiA is sequestered and unable to stimulate 
KaiC phosphorylation. Thus, KaiC dephosphorylates within this complex during the 
Dephosphorylation Phase (69). The formation of KaiCB(A) complexes initiates the 
Dephosphorylation Phase. When KaiC fully dephosphorylates, KaiB dissociates from 
the complex, desequestering KaiA. Crystal structures of KaiB show that it exists as a 
homotetramer with each monomer adopting a fold similar to that of thioredoxin (Fig. 4) 
(72). It contains a single positively charged cleft flanked by two negatively charged 
ridges. Site-directed mutagenesis at those positive residues and deletion of the negative 
residues show that those two regions are important for the proper function of KaiB (72). 
Although KaiB alone is a tetramer, it binds to KaiC as a dimer on the top of the CII ring 
(87, 88). Thus, the KaiB:KaiC complex likely changes the structure of KaiB. In the 
native gel electrophoresis, KaiB does not form a complex with the CI ring of KaiC but 
forms a complex with the CII ring (87). The KaiB:KaiC interaction is strongest when 
KaiC is in its pST phosphoform or mutated to the pST phosphomimics S431D or S431E 
(65, 66). Since residues S431 and T432 are not near surface of KaiC but buried deep 
within the subunit interfaces, KaiB may not interact directly with them. Several crystal 
structures of KaiC in different states of phosphorylation are available (89). Remarkably, 
the structures are virtually identical, including those that do and do not bind KaiB. Thus, 
they do not inform on how KaiB selectively recognizes the pST and pSpT forms of KaiC.   
The KaiB:KaiC complex recruites and sequesters KaiA in a KaiCB(A) complex, in 
which KaiA is unable to stimulate KaiC phosphorylation (65, 66). The KaiCB(A) 
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complex has been solved by electron microscopy (70). The complex also exists in the 
absence of KaiC A-loops, the KaiA-binding site, during the Phosphorylation Phase (90). 
These observations suggest that in the KaiCB(A) complex, KaiA is bound at a site that is 
different from that during KaiC phosphorylation. However, how KaiB forms a complex 
with KaiA and KaiC in this dephosphorylating complex is not known. Unfortunately, the 
EM structure of the KaiCB(A) complex could not resolve the intermolecular interactions 
among these three proteins. 
The binding sites of KaiA or KaiB on KaiC are on the surface of KaiC (70), far away 
from the phosphorylation sites of KaiC. Therefore, KaiA and KaiB must affect KaiC 
phosphorylation sites through an allosteric mechanism. It was believed phosphorylation-
dependent conformational changes in KaiC played a critical role in the timing 
mechanism. Indeed, allostery usually is understood as structural changes at the active 
sites of enzymes induced by ligand binding at distal sites (91, 92). This classic view has 
been developed for decades, and applies to many biological process, such as catalysis, 
signal transduction, gene regulation, and metabolism (93-95). The role of protein 
motions were usually neglected in discussions of allostery. For the past few years, 
however, the roles of the internal motions of proteins have been shown to play important 
roles in allosteric mechanisms (96). Thus, the paradigm of allostery is shifting to include 
dynamics-driven mechanisms. There are an increasing number of examples where 
instead of a ligand-induced structural change stimulating distal active site activity, the 
internal motions of the protein mediate allosteric interactions without conformational 
change (96). In these proteins, long-range communication is regulated by dynamic 
fluctuations (entropic contribution) without structural changes (enthalpic contribution). 
In fact, the possibility of this concept was discussed almost three decades ago (97, 98). 
However, it was not known whether the internal motions could underpin allosteric 
mechanisms. The Kalodimos group reported the first direct experimental support of this 
the dynamic allostery hypothesis in 2006 (Fig. 5) (96). The negative cooperative binding 
of cAMP to catabolite activator protein (CAP) was shown to mediate changes in 
conformational entropy but not conformational changes (96). CAP is a transcription 
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activator that forms a homodimer (99). Each subunit contains a cAMP binding site at the 
N terminus, and a DNA binding site at the C terminus. CAPN is responsible for CAP  
dimerization (100, 101). Two cAMP molecules bind to the N terminus of CAP with 
negative cooperativity and increase CAP’s affinity for DNA through an allosteric effect 
(101). Crystallographic studies of other oligomeric systems suggested that the binding of 
the first ligand may distort the conformation of the other unliganded subunit and resulted 
in the unfavorable second ligand binding (102, 103). However, failure of getting the 
crystal structures of unliganded CAP raised the possibility that other mechanisms might 
affect the negative cooperativity (102, 104, 105). The strong negative cooperativity of 
CAPN (106) allowed characterization of the changes in protein structure and dynamics of 
three distinct states: unliganded state (apo-CAPN), singly liganded state (intermediate, 
cAMP1-CAPN), and the doubly liganded state (cAMP2-CAPN) (96). apo-CAPN exhibits 
flexibility on the ps-ns time scale (Fig. 5). Binding of the first cAMP molecule affected 
 
Figure 5 Overall effect of the sequential cAMP binding to the conformation and 
dynamics of CAPN. apo-CAPN showed flexibility at ps-ns and stability (H/D exchange 
rate). cAMP binding site was flexible shown as wave line. Binding of first cAMP has 
little effect on ps-ns motion and stability; however, it activated slow motion 　 s-ms. In 
addition, it changed the structure of liganded subunit but not the unliganded subunit. 
Binding of second AMP decrease the fast and slow motions and stability (lower H/D 
exchange rate). The lower favorable entropy along with the second ligand binding 
compared with first is the source of the negative cooperativity. This figure is adopted 
from (96).    
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the conformation of the liganded subunit but not second unliganded subunit. Nonetheless, 
the internal motions of both subunits were dramatically affected, especially, on μs–ms 
timescale. Binding of the second cAMP molecule had no effect on the other subunit but 
suppressed both fast and slow motions of almost all residues throughout both subunits 
(96)(Fig. 5), thereby revealing the basis of the negative cooperativity. Interestingly, there 
was no evidence of structural changes in this allosteric mechanism. It was therefore 
concluded that the negative cooperativity of binding of cAMP to CAPN was entirely 
through a dynamics-driven mechanism (96). 
In the recent years, several examples have demonstrated the importance of protein 
motions in regulating allosteric interactions (107, 108). Many techniques have been used 
to detect the protein motions on different time scales, such as fluorescence, ultraviolent 
and visible spectroscopy, Raman spectroscopy, and infrared spectroscopy (Fig. 6) (107). 
Nuclear magnetic resonance (NMR) spectroscopy provides both structural information 
and details on local motions ranging from picoseconds to seconds timescales at multiple 
sites simultaneously (Fig. 6). Measurement of the dynamic states of proteins by NMR 
has filled a major gap in understanding that could not be solved by conventional 
structure-to-function studies. Recent advances in isotopic labeling of proteins and novel 
NMR experiments have dramatically advanced the applicability of NMR spectroscopy to 
protein systems of hundreds of kilodaltons (109).  
In studying the KaiABC system, there are several problems associated with the status 
quo of using static structures to understand the mechanism of the cyanobacterial 
oscillator. For example, there are six X-ray crystal structures of KaiC in different states 
of phosphorylation, but with virtually identical quaternary structures (89). In fact, the 
conformations of the long solvent-exposed tails were also identical among the six KaiC 
phosphoforms, bringing into question whether having the same space group and unit cell 
dimensions suppressed the effects of phosphorylation on KaiC conformation. 
Additionally, electron microscopy has produced low-resolution models of KaiCB(A) and 
KaiB:KaiC complexes, but there is insufficient detail on why, for example, the 
KaiB:KaiC complex depends on the phosphorylation state of KaiC (87). Indeed, the 
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mechanism of KaiA-mediated phosphorylation and KaiB-mediated dephosphorylation of 
KaiC  are still unclear,  because it  is  difficult  to  reconcile the static Kai structures with  
their phosphorylation-dependent interactions and biochemistry. The static structures 
overlook a critical aspect of the oscillator mechanism. Our previous data (86) and 
modeling by others (110) strongly suggest that intramolecular protein dynamics might 
 
Figure 6 Timescale of dynamic processes in protein and the experimental methods that 
can detect fluctuations on each timescale. The figure is adopted from (107). 
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play a central role. We have used a new isotopic labeling strategy and a new type of 
NMR experiment (111) to investigate the dynamic motions in the KaiABC system. We 
believe that this approach, which is a significant departure from the status quo in the 
circadian clock field, will overcome current problems associated with static clock 
protein structures. The clock proteins which we used for NMR experiments are from the 
thermophilic cyanobacterium Thermosynechococcus elongates BP-1 due to their 
superior behavior under NMR conditions. For example, KaiA, KaiB, and KaiC from T. 
elongates have higher solubility and thermostability than their S. elongatus homologs, 
which are critical for high quality NMR spectra. High quality spectra of all Kai protein 
samples were recorded on a Bruker 600 MHz NMR spectrometer equipped with a cryo-
probe. 
Here, the NMR and biochemical results strongly support that KaiA and KaiB mediate 
the KaiC phosphorylation cycle through dynamics-driven allosteric mechanism. Our 
data support a model in which CII ring flexibility is regulated by the KaiC 
phosphorylation state and interactions of KaiC with KaiA and KaiB. However, dynamic 
complex formation between KaiA, KaiB, and KaiC in turn regulates the KaiC 
phosphorylation cycle which leads to changes in the flexibility of KaiC CII ring. 
Importantly, circadian rhythms of CII ring flexibility separate the Phosphorylation and 
Dephosphorylation Phases, thereby revealing how these phases do not interfere with 
each other. Moreover, the flexibility of CII ring is linked to the regulation of ATPase 
activity. The CI ring of KaiC, to which the N terminus of SasA binds, has an ATPase 
activity that oscillates with a circadian rhythm. This ATPase activity regulates a cell 
division checkpoint (51), and thus transduces the KaiABC rhythm along SasA-
dependent output pathways. We have evidence that the flexibility of the CII ring 
regulates CI ATPase activity thereby revealing the source of downstream rhythms.       
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1.2 Protein Dynamics of Supramolecular Complexes by NMR  
 
Nuclear magnetic resonance (NMR) spectroscopy is a powerful technique to 
characterize protein structure and dynamics (112, 113). Protein dynamics measured by 
NMR was first performed nearly 40 years ago (114, 115). Since then, NMR 
spectroscopy has been widely used to determine protein structures, protein-protein 
interactions, and the dynamic states of protein. Indeed, that hundreds of spin-½ nuclei of 
a protein can be observed simultaneously has deepened understanding of many 
biological processes. A series of NMR experiments has been developed to monitor 
protein dynamics across a broad range of time scales, from picoseconds to seconds (Fig. 
7) (111). Fig. 7 shows how a spin-½ nucleus reports conformational exchange between 
two different states. NMR resonance frequencies of the spin in each state is different. As 
shown in the figure 7, large spectral changes can be observed when the exchange rate 
changes. At slow exchange rates, two peaks indicate the two different conformational 
states. When the exchange rate increases, the peaks become exchange broadened, and 
will merge to one peak as the exchange rate increases. Under fast exchange, only one 
sharp peak is observed because the exchange rate is much faster than the difference in 
chemical shifts between the two states. The corresponding NMR experiments for 
detection of protein motions on different time scales are listed on the left side of Fig. 7, 
which shows that the sensitivity of NMR experiments depends on the timescale of 
protein dynamics. 
In the past few years, NMR experiments have been developed to measure the 
dynamics of supramolecular protein complexes (109). The development of stronger 
magnets and cryoprobes (116) has dramatically increased the power of the NMR 
approach to understanding protein function. These advances have been aided by a new 
isotopic labeling strategy that has pushed the NMR limit on protein size to several 
kilodaltons (117). Combined with the methyl-TROSY experiment (109), it provides 
high-resolution structural and dynamic information on supra-protein protein complexes. 
Moreover, NMR spectroscopy provides information about multiple sites simultaneously.  
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Figure 7 Comprehensive NMR dynamics experiments over timescales. This figure is 
adopted from (111). 
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Thus, NMR is a unique and powerful technique for studying protein structure and 
dynamics. The new isotopic labeling strategy enables specific labeling of methyl group 
of Ile, Leu, Val, or Met as probes to study protein structure and dynamics in high-
molecular-weight system (109). Methyl groups are often located at hydrophobic cores of 
proteins and many of them tend to be dynamic. Thus, the relaxation rate is relatively 
slow, resulting in high quality methyl spectra (109, 118). Because methyl groups are 
sensitive to protein structure and dynamics, they are outstanding probes of protein 
function (119-122). Since the methyl groups are selectively protonated against a highly 
deuterated background their sensitivity is maximized, which is critical for 
supramolecular protein complexes (123). This approach has been used to study protein-
ligand interactions (124), fast and slow side-chain dynamic motions (122), dynamics of 
protein folding (125), and even for the detection of proteins and protein complexes in in-
cell NMR experiments (126). Commercially available isotopically labeled α-ketoacids 
(Fig. 8) serve as amino acid precursors for the incorporation of methyl-labels into the 
side-chains of valine, leucine, and isoleucine residues of proteins overexpressed in E. 
coli using D2O-based minimal media (127). Different labeling patterns of these ILV 
residues can be used for different purposes. For example, proteins from Fig. 8, a and c 
with linearized 13C spin-systems are used for resonance assignments. The same samples 
can be used to obtain not only chemical shifts for assignments of backbone and 13C spins 
but also 3JCγCO scalar couplings. In another case, the 13CH3/12CD3 labeling scheme from 
Fig 8, c and f is much better than that from Fig. 8, b and e for methyl-TROSY 
experiments (127). In order to obtain the isotopically labeled protein, α-ketobutyric 
acids are added into D2O-based minimal media 1 h before induction. Methyl-transverse 
relaxation optimized spectroscopy (methyl-TROSY) experiment is based on the 
Heteronuclear Multiple Quantum Coherence (HMQC) experiment and exploits enhanced 
the TROSY effect on 13CH3 (AX3) spin systems (117). The experiment preserves the 
slowly relaxing pathways of magnetization (128). A high level of deuteration is critical 
to maximize the TROSY effect to reduce the external proton relaxation pathways. The 
original TROSY experiment was applied to A-X systems, such as backbone 15N-1H (128) 
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and aromatic 13C-1H spin systems (129). The application of the TROSY effect to methyl 
groups (13CH3, 13CH2D, and 13CHD3) was optimized from the HMQC experiment (117, 
130). The TROSY effect on 13CH3 spin system is called Methyl-TROSY experiment. 
Methyl-TROSY is sensitive to the slowly relaxing component of 13CH3 spin systems. 
This experiment in combination with highly deuterated proteins 13CH3 labeled at the 
methyl groups of valine, leucine, and isoleucine, increases the methyl-TROSY 
sensitivity and resolution to systems reaching 700 kDa. Using this approach, deep 
insights have been recently obtained on several supramolecular protein complexes, such 
as ClpP protease (305 kDa) (131), and the 20S proteasome (670kDa) (109). Here, we use 
methyl-TROSY experiment and biochemical studies to understand the role of protein 
dynamics during the KaiC phosphorylation cycle.    
 
 
Figure 8 Partial commercially available isotopically labeled α-keto acid precursors. 
These biosynthesis precursors are used in E. coli growth of selectively methyl-labeled 
proteins. a,d) selectively labeled α-ketobutyrates for isoleucine. b,c,e,f) selectively 
labeled α-ketoisvalerates for valine and isoleucine. This figure is adopted from (127).  
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CHAPTER II 
  MECHANISM OF THE PHOSPHORYLATION PHASE 
     
2.1 Introduction  
 
All circadian oscillators have a Phosphorylation Phase that is critically important to 
clock function (86). For example, mutation at a phosphorylation site in human Per2, 
Ser662 to Gly, which decreases Per2 phosphorylation in vitro (25), has been identified to 
be the cause for Familial Advance Sleep-Phase Syndrome (FASPS) (25, 27). Mutation at 
human Per3, Val647 to Gly, has also been linked to Delayed Sleep-Phase Syndrome 
(DSPS) (28). In cyanobacteria, the circadian rhythm of KaiC phosphorylation is key to 
downstream circadian rhythms of gene expression. Mutations at phosphorylation sites of 
KaiC cause arrhythmicity (59).    
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Figure 9 KaiC phosphorylation order diagram. ST: unphosphorylated Serine 431 and 
unphosphorylated Theronine 432; SpT: unphosphorylated S431 and phosphorylated T432; 
pSpT: phosphorylated S431 and phosphorylated T432; pST: phosphorylated S431 and 
unphosphorylated T432. KaiC phosphorylation and dephosphorylated undergoes four 
different phosphorylated state: ST → SpT → pSpT→ pST→ ST. In our model, the 
Pphosphorylation Phase is indicated as red part, the Transition Phase showed as blue and 
the Dephosphorylation Phase is green and whole cycle start anew. 
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However, the mechanism of the Phosphorylation Phase is not fully understood for any 
system, creating a major gap in understanding for the field (Fig. 9). For the 
cyanobacterial oscillator, it has long been known that KaiA induces KaiC 
phosphorylation (63, 64). Previously, our laboratory found that the exposed and buried 
positions of the A-loops of KaiC is the switch for phosphorylation and 
dephosphorylation, respectively (Fig. 10A and B) (86). In addition, we also determined 
that KaiA binds via its C-terminal domain to KaiC as evidenced by the NMR structure of 
C-terminal domain of KaiAC in complex with a KaiC-derived peptide that includes the 
A-loops (85). Here, the x-ray crystal structure of S. elongatus KaiC shows that residues 
488-497 (Fig.10A magenta part in KaiC) are buried in a looped conformation (87). We 
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Figure 10 The NMR structure of the KaiA-KaiC A-loop complex docks on the top of 
KaiC structure and x-ray crystal structures of KaiC. (A) This is a docking model of two 
independent x-ray crystal structures. The two subunits of the KaiA dimmer of the 
KaiA-KaiC A-loop complex are shown as gray and magenta ribbons(85). (B) The KaiC 
x-ray crystal structure in the bottom is the same structure shown in  (60). (B) The N- 
and C-terminal domains of five subunits of KaiC (PDB ID : 1tf7) are shown as green 
surface, whereas the remaining subunit are shown as transparent surface. The A-loops 
are shown as magenta ribbon ATP molecules are red and S431 and T432 are yellow
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refer to the segment as A-loop. Residues 489-519 are referred as “Tail”. Site-directed 
mutagenesis and negative-stain electron microscopy studies also revealed that KaiA 
binds exclusively to the CII domain of KaiC (78). These studies suggested that A-loop 
exposure in the KaiA:KaiC complex induces KaiC phosphorylation. Indeed, mutants of 
KaiC developed in our lab in which A-loop exposure was mimicked are hyper- 
phosphorylated (86). Although these discoveries advanced understanding, they could not 
explain how A-loop position and the active site of KaiC are coupled across 20 Å (Fig. 
10B). In the dephosphorylated state of KaiC, the γ-phosphate groups of ATP are 8.5 Å 
and 6.6 Å away from the hydroxyl oxygens of KaiC phosphorylation sites S431 and 
T432, respectively (Fig. 11B). However, the upper distance limit for phosphoryl transfer 
between the phosphorus atom and acceptor oxygen is 5.0 Å, with the oxygen atoms 
perfectly aligned with the phosphate (84). In other words, when the A-loops are exposed, 
the distance between the bound ATP molecules and the sites of phosphorylation must 
decrease by at least 2 Å for phosphoryl transfer (84) to occur. The A-loops in the six 
crystal structures of KaiC are in the buried conformation, and thus provide little insight 
into how A-loop position affects the spatial rearrangement or dynamics of the active 
site(89). 
    NMR spectroscopy has been invaluable in revealing that dynamics can play key roles 
in dictating  protein functions (108, 132). Increasing number of studies have demostrated  
that protein dynamics, rather than structural changes, governs the allosteric mechanism 
by which protein functions are modulated (108, 132, 133). For example, PDZ3 domain 
from PSD-95/SAP90 shows a dynamics-driven allosteric effect (108). This PDZ3 
domain binds to its natural partner CRIPT protein at C terminus. In heterologous cells, 
CRIPT causes a redistribution of PSD-95 to microtubules. In brain, CRIPT colocalizes 
with PSD-95 in the postsynaptic density and can be coimmunoprecipitated with PSD-95 
and tubulin (134). The PDZ3 domain from PSD-95/SAP90 contains  an  additional  
helix(α3) at its C terminus. The function of α3 has been found to mediate the binding 
affinity for CRIPT protein through dynamic allostery. α3 is distal from PDZ3 and 
CRIPT  binding  site. However, removal of this additional helix decreased by 21 fold the 
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binding affinity for a CRIPT peptide which includes nine C-terminal residues. The 
structure of PDZ3 domain does not change upon the α3 deletion but dynamics on the ps-
ns time scale increases dramatically. This hidden dynamic allostery demonstrated that 
allostery could arise solely from dynamics changes rather than structural changes. 
Therefore, we believe that the repositioning of the A-loops may have similar function to 
that of α3 helix of PDZ3 domain. Our hypothesis for the mechanism of the 
Phosphorylation Phase is that KaiA stabilizes a state of KaiC in which the CII ring is 
 
Figure 11 ATP is too far from phosphorylation sites. The sites of phosphorylation of 
KaiC, S431 and T432, and relevant distances (PDB ID: 1tf7). The prime on E318’from 
the adjacent subunit. ATP molecules bounds to KaiC hexamer in the interface of two 
subunits at CII domain. The distance between 　 P of ATP to hydroxyl group of T432 
and S431 are 6.6 and 8.6 Å, respectively. The prime on E318’, the putative catalytic 
glutamate, indicates an adjacent subunit. The upper distance limit between the 
phosphorus atom and acceptor oxygen for phosphoryl transfer is 5.0 Å, according to an 
analysis by Dr. Mildvan (84). Thus, the distances between the γP of ATP and the 
hydroxyls of S431 and T432 are too far for phosphoryl transfer. 
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flexible, which we propose is critical to KaiC phosphorylation. Here, we will 
demonstrate that the mechanism of KaiA-mediated KaiC phosphorylation is likely one 
of dynamic allostery. When the A-loops are buried in the absence of KaiA, ATP 
molecules are tightly bound in a KaiC hexamer, unable to approach S431 and T432. By 
comparison, when the A-loops are exposed, either by mutation or by KaiA capture, the 
CII ring becomes significantly flexible, which we think allows ATP to approach S431 
and T432 for phosphoryl group transfer. 
To test this hypothesis, we used isotopic labeling and NMR to determine the dynamic 
state of KaiC. With regard to probing dynamics of supramolecular protein complexes 
such as those of the Kai proteins (600 kDa), recent advances in isotopic labeling and 
NMR methodology now make it possible to obtain atomic-resolution details proteins, 
like 20S proteasome (670 kDa) (109). We prepared U-[2H,15N], Ile-[δ1 13CH3]-labeled 
KaiC, U-[2H,15N], Ile-[ δ1 13CH3]-labeled KaiC-SE, U-[2H,15N], Ile-[δ1 13CH3]-labeled 
KaiC-EE, and U-[2H,15N], Ile-[ δ1 13CH3]-labeled KaiC-ET to probe KaiC dynamics by 
recording the methyl-TROSY spectra. X and Y in KaiC-XY represent the amino acyl 
residues at positions 431 and 432, respectively. Alanyl and glutamyl substitutions at 
these positions have been shown to mimic the dephosphorylated and phosphorylated 
states of S431 and T432 (66, 86, 90). A truncation KaiC variant, U-[2H,15N], Ile-[ δ1 
13CH3]-labeled KaiC-EE487, which mimics the exposed A-loops state of KaiC-EE, was 
generated to compare the dynamics change upon A-loop exposure. As the amino acyl 
substitutions reside in the CII ring, it is reasonable to assume that these spectral 
differences largely reflect differences in CII ring dynamics. Indeed, SAXS and 
fluorescence observations by Murayama et al. has suggested that it is the CII ring that 
undergoes stepwise changes compared with the CI ring (135). Our results revealed that 
KaiC-EE and KaiC-ET adopt the more rigid conformations than wt-KaiC, which 
indicated that the CII ring of KaiC is flexible during the Phosphorylation Phase and A-
loop exposure can further increases the flexibility of the CII ring. In addition, phospho-
T432 has been found to sustain KaiC CII ring flexibility, whereas phospho-S431 reduces 
the flexibility of the CII ring which also offset phospho-T432 effect. The features can 
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explain the natural phosphorylation order: ST → SpT → pSpT. Below, it will be 
demonstrated that the Phosphorylation Phase is regulated by CII ring flexibility. 
 
2.2 Materials and Methods1 
 
    S. elongates KaiA and KaiB expression and purification. The genes encoding KaiA 
and KaiB were cloned into the pET32a+ vector (Novagen) between the BamHI and NcoI 
sites. The resulting plasmids were used to transform Escherichia coli BL21(DE3) 
(Novagen) and the sequences were then confirmed (Gene Technologies Laboratory, 
Texas A&M University). Transformed E. coli cultures were incubated at 37°C until 
OD600 reached about 0.6; at this point, a final concentration of 200 μM isopropyl β-D-
thiogalactopyranoside (IPTG) (Research Product International) was added for 
overexpression. Cells were harvested after 12 h overexpression at 25°C and pellets were 
then resuspended in 20 mM Tris-NaOH, 500 mM NaCl, pH 7.0. Cell suspensions were 
passed twice through a chilled French press cell, and lysates were clarified by 
centrifugation at 20,000 x g for 60 min at 4°C. Tagged proteins were isolated on a Ni-
charged chelating column. Protease and ATPase were removed by anion-exchange 
chromatography (buffer A: 20 mM Tris Base, 20 mM NaCl, Ph 7.0; buffer B: 20 mM 
Tris Base, 1M NaCl, Ph 7.0; gradient: 0-80% buffer B over 165 mL column volumes). 
The tagged proteins were buffer exchanged to enterokinase (EK) cleavage buffer 
(Novagen) and reactions with 1 unit/ml EK were carried out at room temperature in 30-
45 mL proteins. KaiA and KaiB were separated from Thioredoxin-His6 tag by a second 
Ni-charged chelating column. All proteins were analyzed for purity by SDS-PAGE and 
dialyzed against a phosphorylation assay buffer (20 mM Tris Base, 150 mM NaCl, 0.5 
mM EDTA, 5mM MgCl2, 1 mM ATP, pH 8.0). Proteins were concentrated by an 
Amicon Stirred Ultrafiltration Cell (MILLIPORE) with a YM-10 untrafiltration 
_____________ 
1 Supplementary information of materials and methods are in the Appendixes A-F. 
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membrane (MILLIPORE) and stored in a -80°C freezer. Coomassie Plus (Pierce) was 
used as a Bradford Assay reagent for protein concentration determination. 
S. elongates KaiC expression and purification. Gene encoding  KaiC was cloned into 
the pGEX-6P-2 vector (GE Healthcare) between the BamHI and XhoI sites, and the 
resulting plasmids were used to transform E. coli DH5α (Novagen), which produced 
more soluble recombinant KaiC than did E. coli BL21(DE3) (Novagen). Protein 
purification, analysis and storage were similar as for S. elongates KaiA and KaiB and 1 
mM ATP was used in all solutions.  
T. elongatus KaiA, KaiB, KaiC and KaiC mutants expression and purification. The 
genes encoding KaiA, KaiB and KaiC from T. elongatus were cloned into the pET28a+ 
vector (Novagen) between the NdeI and HindIII sites. The resulting plasmids were used 
to transform Escherichia coli BL21(DE3), and  the sequences were confirmed (DNA 
Sequencing Facility, University of California, Berkeley). Transformed E. coli cultures 
were incubated at 37°C until OD600 reached about 0.6; at this point, a final concentration 
of 200 μM isopropyl β-D-thiogalactopyranoside (Research Product International) was 
added for overexpression. Cells were harvested after 12 h overexpression at 25°C, and 
pellets were resuspended in 20 mM Tris-NaOH, 500 mM NaCl, pH 7.0. Cell suspensions 
were passed twice through a chilled French press cell, and lysates were clarified by 
centrifugation at 20,000 x g for 60 min at 4°C. Tagged proteins were isolated on a Ni-
charged column. Proteins were buffer exchanged to 20 M Tris Base, 500 mM NaCl and 
20 mM Imidazole and 100 μl 100 μM ULP1 protease were added for SUMO-His6 tag 
removal. The cleavage reaction was carried out at room temperature 16 h in 15 mL 
volume. Kai proteins were separated from SUMO-His6 tag protein by a second Ni-
charged column and followed by gel filtration chromatography on a Superdex 200 
HiLoad 16/60 prep grade column (GE Healthcare) for KaiC and a Superdex 75 HiLoad 
16/60 prep grade column (GE Healthcare) for KaiA and KaiB. Buffers were exchanged 
to 20 mM Tris Base, 150 mM NaCl, 0.5 mM EDTA, 5mM MgCl2, 1 mM ATP, pH 7.0 
for the phosphorylation assay and 20 mM Tris Base, 50 mM NaCl, 1 mM MgCl2, 5 mM 
DTT, 1 mM ATP, pH 7.0 for the binding assay and NMR experiments. Proteins were 
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concentrated by Amicon Stirred Ultrafiltration Cell (MILLIPORE) and stored in a -80°C 
freezer. KaiA, KaiB, and KaiC did not lose function after repeated cycles of freezing and 
thawing. One liter LB yields ~ 440 nmol of KaiA, ~ 1728 nmol of KaiB, and ~ 240 nmol 
of KaiC and KaiC mutants. Coomassie Plus (Pierce) was used as a Bradford Assay 
reagent for protein concentration determination. For purification of KaiC, all the 
solutions were prepared with 1 mM ATP.  
    U-[15N, 2H], Ileδ1-[13C,1H]-KaiC (KaiC, KaiC-SE, KaiC-EE, KaiC-ET, KaiC-EE487) 
expression and purification. Expression: Follow protocol A-10 and the amino acid 
precursor adopted scheme is in Fig. 12. Purification: Follow protocol A-11. Note that 
BioExpress (Cambridge Isotope Laboratories) was used to increase the growth rate of E. 
coli. 
    ULP1 protease expression and purification. Expression: Follow protocol A-8. 
Purification: Follow protocol A-12 but stops after the elution step of 1st Ni-NTA column. 
Note that Ulp1 is not stable in buffers where NaCl is at a concentration lower than 100 
mM. For long-term storage, add equal volume of glycerol into the Ulp1 elution sample 
from Ni-NTA column and store at -80°C. Ulp1 elution sample can be diluted to a final 
concentration of 200 μM before adding glycerol. Therefore, the final Ulp1 stock (stored 
at -80°C) will be 100 μM in the buffer of 25 mM NaH2PO4, 250 mM NaCl, 125 mM 
imidazole, 50% glycerol, pH 8.0. 
12C 12C
D
D
13CH3
12C
O
O
OH 12C 12C
D
D
13CH3
D
12CD
α-Keto butyric acid U-[2H, 12C]-δ1-[13CH3] isoleucine  
Figure 12 Methyl labeling strategy. Amino acid precursor used to produce proteins 
with 13CH3-isoleucine (δ1). Isoleucine (δ1) methyl group is indicated in red. This 
figure is adopted from (123). 
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    In vitro S. elongatus KaiC phosphorylation oscillation. All S. elongatus KaiC proteins 
were preincubated at 30°C for 16 h to allow samples to reach steady state 
hypophosphorylation before using them in experiments. KaiC proteins were then 
incubated with KaiA and KaiB in buffer (20 mM Tris, 150 mM NaCl, 0.5 mM EDTA, 
5mM MgCl2, 1 mM ATP, pH 8.0) at 30°C. The final concentrations of KaiA, KaiB, and 
KaiC were 1.2, 3.5, and 3.5 μM, respectively. Aliquots (37 μl) of the reaction mixtures 
were collected every 2 h by a Gilson 223 automated liquid handler/injector (Fig. 13). All 
the reaction was stopped by the addition of 7μl SDS-PAGE gel loading dye (100 mM 
Tris Base at pH 6.8 with 4% SDS, 0.2% bromophenol blue, 20% glycerol, and 400 mM 
 
Figure 13 Robot Collector. Set up of Gilson 223 automated liquid handler/injector for 
collecting the aliquoit from the in vitro reaction.  
 
  
34
β-mercaptoethanol). A sample (7 μl) for each indicated time point was loaded onto 9 x 
10 cm SDS polyacrylamide gels (4% of acrylamide/bisacrylamide for stacking gel, and 
6.5% of acrylamide/bisacrylamide for running gel) with 15 wells (10 x 3 x 0.75 mm). 
The experiments were run at a 60 voltages glycine buffer for 40 minutes and then 140 V 
for 1 h 50 minutes, with the electrophoresis cell surrounded by ice water. Gels were 
stained with Coomassie brilliant blue, and the percentage of KaiC that was 
phosphorylated in each lane was determined by densitometric analysis by using Image J 
(National Institutes of Health) and PeakFit (SeaSolve Sofeware, Inc.).  
    T. elongatus KaiC protein kinetics. Recombinant T. elongatus KaiA, KaiB, and KaiC 
proteins were preincubated at 30°C for 16 h to allow samples to reach steady state 
hypophosphorylation before using them in experiments. KaiC proteins were then 
incubated with KaiA and KaiB in buffer (20 mM Tris, 150 mM NaCl, 0.5 mM EDTA, 
5mM MgCl2, 1 mM ATP, pH 7.0) at 30°C. The final concentrations of KaiA, KaiB, and 
KaiC were 1.2, 3.5, and 3.5 μM, respectively. Aliquots (37 μl) of the reaction mixtures 
were collected following the designed time course. The reaction was stopped by the 
addition of 7μl SDS-PAGE gel loading dye (100 mM Tris, 4% SDS, 0.2% bromophenol 
blue, 20% glycerol, 400 mM β-mercaptoethanol, pH 6.8). A sample (7 μl) of each 
reaction was loaded onto 9 x 10 cm SDS polyacrylamide gel (4% of 
acrylamide/bisacrylamide for stacking gel, 6.5% of acrylamide/bisacrylamide for 
running gel) with 15 wells (10 x 3 x 0.75 mm). 
T. elongatus KaiC variants kinetics. Recombinant T. elongatus KaiC proteins were 
preincubated at 30°C for 16 h to allow samples to reach steady state 
hypophosphorylation before using them in experiments. KaiC proteins were then 
incubated with KaiA and KaiB in buffer (20 mM Tris, 150 mM NaCl, 0.5 mM EDTA, 
5mM MgCl2, 1 mM ATP, pH 7.0) at 30°C. The final concentrations of KaiA, and KaiC 
were 1.2, and 3.5 μM, respectively. Aliquots (37 μl) of the reaction mixtures were 
collected following the designed time course.    
    Binding Assay. All column bindng assays including KaiC-CII alone experiments were 
carried out using a Superdex 200 10/300 GL gel filtration column (GE Healthcare). 
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Ferritin (440 kDa), albumin (67 kDa), ovalbumin (43 kDa), and chymotrypsinogen A 
(25 kDa) were used as molecular mass markers.     
   KaiC-CII hexamerization.Recombinant CII variants (final concentration:10 μM) in 
100 μl binding buffer (20 mM Tris, 50 mM NaCl, 1 mM MgCl2, 5 mM DTT, 1 mM 
ATP, pH 7.0) were incubated at 25°C about 0.5 h, and then applied to a Superdex 200 
10/300 GL column with a flow rate of 0.8 ml/min. 
    KaiA and KaiC-CII binding. Recombinant KaiA and KaiC-CII variants were mixed in 
1:1 ratio (10 μM: 10 μM) in 300 μl binding buffer (20 mM Tris, 50 mM NaCl, 1 mM 
MgCl2, 5 mM DTT, 1 mM ATP, pH 7.0) at 25°C for 0.5 h. Then, the mixture was 
applied to a Superdex 200 10/300 GL column with a flow rate of 0.8 ml/min. 
    NMR Sample Preparation and Spectroscopy. NMR sample preparation: Follow 
protocol C-1. NMR sample information: Please see Table 1. NMR spectroscopy: Follow 
Protocol C-2.  
 
2.3 Results  
 
Recombinant Kai proteins are functional. To establish that the recombinant Kai 
proteins are functional in generating the 24h rhythm, the in vitro KaiC phosphorylation 
oscillation with recombinant Kai proteins was carried out in the standard condition 
(Please see below or materials and methods). Recombinant KaiA, KaiB, and KaiC from 
S. elongatus and ATP were mixed in a sterile microcentrifuge tube and the reaction was 
incubated at 30°C with final concentrations of 1.2 μM, 3.5 μM, 3.5 μM, and 1 mM, 
respectively. Aliquots were collected by a Gilson 223 automated liquid handler/injector 
every two hours for three days. The reactions were stopped by the addition of 7μl SDS-
PAGE gel loading dye and, then, heating at 60°C for 15 mins. Each aliquot was 
subjected to 6.5% SDS-PAGE. KaiC displays two bands, with the upper and bottom 
bands indicating hyperphosphorylated and hypophosphorylated KaiC proteins (Fig. 14B). 
These gels were processed using image analysis software Image J (National Institutes of 
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Table 1 NMR Sample Condition and Experiment for CHAPTER II 
Sample Experiment Sample detail Experiment detail 
KaiC 
U-[15N, 2H]-Ileδ1-[13C, 1H]-
FLAG-KaiC 
Methyl-TROSY Concentration:  15 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM 
MgCl2, 5 mM DTT, 1 mM ATP, pH 7.0, 10 
μM DSS, 0.02% NaN3, 99.96% D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=128 
40 °C 
U-[15N, 2H]-Ileδ1-[13C, 1H]-
FLAG-KaiC-SE 
Methyl-TROSY Concentration:  8 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM 
MgCl2, 5 mM DTT, 1 mM ATP, pH 7.0, 10 
μM DSS, 0.02% NaN3, 99.96% D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=256 
37 °C 
U-[15N, 2H]-Ileδ1-[13C, 1H]-
FLAG-KaiC-EE 
Methyl-TROSY Concentration:  16 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM 
MgCl2, 5 mM DTT, 1 mM ATP, pH 7.0, 10 
μM DSS, 0.02% NaN3, 99.96% D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=128 
40 °C 
U-[15N, 2H]-Ileδ1-[13C, 1H]-
FLAG-KaiC-ET 
Methyl-TROSY Concentration:  14 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM 
MgCl2, 5 mM DTT, 1 mM ATP, pH 7.0, 10 
μM DSS, 0.02% NaN3, 99.96% D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=128 
40 °C 
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Table 1 continued 
Sample Experiment Sample detail Experiment detail 
U-[15N, 2H]-Ileδ1-[13C, 1H]-
FLAG-KaiC-1-487-EE 
Methyl-TROSY Concentration: 8 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM 
MgCl2, 5 mM DTT, 1 mM ATP, pH 7.0, 10 
μM DSS, 0.02% NaN3, 99.96% D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=224 
37 °C 
KaiC-CI 
U-[15N, 2H]-Ileδ1-[13C, 1H]-
FLAG-KaiC-CI-1-247 
Methyl-TROSY Concentration: 6 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM 
MgCl2, 5 mM DTT, 1 mM ATP, pH 7.0, 10 
μM DSS, 0.02% NaN3, 99.96% D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=256 
40 °C 
KaiC-CII-EE 
U-[15N, 2H]-Ileδ1-[13C, 1H]-
FLAG-KaiC-CII-249-518-
EE 
Methyl-TROSY Concentration: 3 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM 
MgCl2, 5 mM DTT, 1 mM ATP, pH 7.0, 10 
μM DSS, 0.02% NaN3, 99.96% D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=256 
25 °C 
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Health) and PeakFit (SeaSolve Sofeware, Inc.) for quantification by densitometry. The 
proportion of phosphorylated KaiC ranged from 30% – 60% during the cycle. The KaiC 
phosphorylation cycle pattern is similar to that previously reported by the Kondo group 
 
(A) 
(B) 
 
Figure 14 In vitro KaiC phosphorylation oscillation. (A) KaiA(71), KaiB(87, 136), and 
KaiC(60) crystal structures. (B) In vitro KaiC phosphorylation oscillation. SDS-PAGE 
of KaiC phosphorylation (top) and KaiC phosphorylation level (bottom).   
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(58). Here, my data strongly indicates that recombinant Kai proteins from our lab are 
functional and therefore can be used to study the mechanism of the central oscillator.  
    The Kai proteins we used for NMR experiments are from T. elongatus because they 
are more stable under NMR conditions compared to Kai proteins from S. elongatus. Kai 
proteins from T. elongatus have better behavior in terms of expression, stability, and 
solubility, and they also tolerate higher temperatures. For big proteins such as KaiC, 
high temperature is critical in many cases for optimal spectral resolution. These 
properties of T. elongatus Kai proteins make them more suitable for experimental study 
by NMR. Kai proteins from S. elongatus and T. elongatus share sequence similarities of 
greater than 80% except for KaiA, which shares about 46% similarity between the two 
homologs. However, the conserved C-terminal domain of KaiA from the two species 
(residues 180-283), which binds to KaiC, share 61% similarity. To ensure Kai proteins 
from T. elongatus have the same functionality as Kai proteins from S. elongatus, KaiC 
phosphorylation kinetic assays were carried out under the same condition for 24 h at 
30°C. The reaction mixture contained KaiA, KaiB, KaiC, and ATP in final 
concentrations of 1.2 μM, 3.5 μM, 3.5 μM, and 1 mM, respectively. The KaiC 
phosphorylation kinetics profile was highly similar to that S. elongatus. KaiA stimulates 
KaiC phosphorylation and KaiC remains in a state of hyperphosphorylation in the 
absence of KaiB (Fig. 15). However, in the presence of both KaiA and KaiB, KaiC first 
phosphorylates, and after it reaches the hyperphosphorylation state, starts to 
dephosphorylate. By comparison, KaiC alone or in the presence of KaiB 
dephosphorylate over time. The first 24 h KaiC phosphorylation cycle from T. elongatus 
has the same kinetics profile as that of S. elongatus KaiC (86). This similarity indicates 
that Kai proteins from T. elongatus behave similarly as Kai proteins from S. elongatus. 
Fluorescence anisotropy results published earlier by our group also support the 
hypothesis  that  interactions  from  T. elongatus and  S. elongatus are similar (86).  Thus,  
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KaiC phosphorylation kinetics data suggest that recombinant Kai proteins from T. 
elongatus can be used to understand the mechanism of the S. elongatus oscillator.   
     A-loop position affects KaiC dynamics. KaiA enhances KaiC phosphorylation, while 
KaiC alone dephosphorylates. How KaiA enhances KaiC phosphorylation is not clear. 
 
Figure 15 In vitro 24h phosphorylation of KaiC. (A) SDS-PAGE gel showing 
phosphorylation of KaiC in the presence or absence of KaiA and KaiB. (B) 
Densitometry analysis plotted from (A).  
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The NMR structure of the KaiA:KaiC peptide complex showed that KaiA binds to KaiC 
A-loops (Fig. 11A) (85), suggesting that the A-loops in an ensemble of KaiC molecules 
exist in a dynamic equilibrium between buried and exposed states. KaiA increases KaiC 
phosphorylation by stabilizing the exposed state of A-loops through direct binding to the 
A-loops. By contrast, in the crystal structure of phosphorylated and unphosphorylated 
KaiC (60, 89), the A-loops are buried, and the γ-phosphate group of ATP was 8.5 Å and 
6.6 Å from the hydroxyl oxygen of S431 and T432, respectively (Fig. 11). The distance 
between the A-loops and phosphorylation site is about 20Å (Fig. 10B). The structural 
information does not explain the specific mechanism by which KaiA enhances KaiC 
phosphorylation. Prompted by the hidden dynamic allostery mechanism (108), we 
proposed that A-loops exposure probably significantly affects the dynamics of KaiC and 
that these dynamics are required for phosphorylation.  
   Due to the size of the KaiC hexamer (nearly 360 kDa as a hexamer), no significant 
signal would be generated from traditional NMR experiments. For that reason, we used 
the methyl-TROSY NMR experiment together with the isotopic labeling methods, which 
have been shown to be powerful in increasing the sensitivity and resolution of NMR of 
supra-molecular systems (137, 138). Methyl-TROSY produces spectra with improved 
resolution and signal to noise and this method pushes up the limitation of protein size by 
NMR to >700 kDa (109). To probe KaiC dynamics, we prepared the following NMR 
samples: U-[2H,15N], Ile-[ δ1 13CH3]-labeled wt-KaiC, U-[2H,15N], Ile-[ δ1 13CH3]-
labeled KaiC-SE, U-[2H,15N], Ile-[ δ1 13CH3]-labeled KaiC-EE, U-[2H,15N],  Ile-[ δ1 
13CH3]-labeled KaiC-ET, and  U-[2H,15N], Ile-[ δ1 13CH3]-labeled KaiC-EE487. The 
first four KaiC variants mimic the different phosphoforms of KaiC, and KaiC-EE487 
mimics the exposure of the A-loops from KaiC-EE. We used α-ketobutyric acid-4-
13C,3,3-d2 sodium salt hydrate, an amino acid precursor, and this chemical only allowed 
the methyl group at δ1 of Ile to be labeled. The purification protocols are described in 
the materials  and  methods.  The  concentrations  of  U-[2H,15N], Ile-[ δ1 13CH3]-labeled  
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Figure 16 Methyl-TROSY spectra of wt-KaiC, KaiC-SE, KaiC-EE, KaiC-ET, and 
KaiC-EE487. Fifteen selected peaks are boxed for comparison. Sample conditions and 
NMR parameters are described in Table 1. Note that the spectra contour levels are 
plotted at the same relative contour level. 
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KaiC, U-[2H,15N], Ile-[ δ1 13CH3]-labeled KaiC-SE, U-[2H,15N], Ile-[ δ1 13CH3]-labeled 
KaiC-EE, U-[2H,15N], Ile-[ δ1 13CH3]-labeled KaiC-ET, and U-[2H,15N],Ile-[δ1 3CH3]-
labeled KaiCEE487 are 15, 8, 16, 14, and 8 μM, respectively. Methyl-TROSY spectra 
were collected at 40°C, except for the KaiC-SE sample, which was collected data at 
37°C due to its instability. All spectra were collected on a Bruker 600 MHz Avance III 
NMR spectrometer equipped with a cryogenically cooled probe-head with the number of 
scans ranging from 32 to 128. The difference in concentrations and number of scans 
were considered when the spectra were analyzed. Data are shown in Fig. 16. Overall, the 
spectra were very similar in term of chemical shift (Fig. 16). Since phosphorylation sites 
are located on the CII domains, the spectral differences mostly arise from the CII rings. 
Line shape analysis suggests that phosphorylation at S431 significantly restricts the μs-
ms time scale CII ring motions, presumably through enhanced electrostatic interaction 
between CII domains (89). These spectra were used to assign resonances to the CI and 
 
                                                            
Figure 16 Continued  
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CII domains of full-length KaiC spectra. Methyl-TROSY line shapes of several 
resonances, including those assignable to the CII ring, are significantly broader in wt-
KaiC and the KaiC-SE than in the KaiC-EE and KaiC-ET (Fig. 17B, panels 1-4). Thus, 
phospho-S431 restricts μs – ms time scale CII ring motions, presumably through 
enhanced electrostatic interactions between CII domains (89). KaiC-EE shares spectral 
signatures with KaiC and KaiC-SE that are absent in KaiC-ET (Fig. 17C, panel 1-4), 
supporting the notion that phospho-T432 preserves some CII ring flexibility even in the 
presence of phospho-S431. As shown earlier, KaiC phosphorylation initiates upon 
selective capture of the A-loops in their exposed position by KaiA (78, 85, 86). For the 
KaiC and KaiC-SE, the A-loops occasionally sample the exposed position, thereby 
making themselves available for capture by KaiA. For the rigid KaiC-ET, in contrast, the 
A-loops are likely trapped in the buried position, contributing to the stability of the CII 
ring. Indeed, their exposure, as mimicked by their truncation, increases flexibility (Fig. 
17, A-D, panel 5). Although the methyl-TROSY spectrum of this KaiC variant is similar 
to those of the ST and SpT forms, unique spectral features from A-loop exposure (Fig. 
17D) probably reflect the conformational and dynamic changes critical to the induction  
 of KaiC phosphorylation. Since KaiC487 is constitutively hyperphosphorylated (86), 
this data strongly supports the idea that KaiC phosphorylation requires a flexible CII ring 
that is stabilized by KaiA capture of exposed A-loops.   
     CII domain dominates the dynamics of KaiC. To confirm that KaiC CII ring 
flexibility specifically changes during the ordered phosphorylation of KaiC, we 
decoupled CII variants from CI domains by generating CII domains alone and tested 
their hexamerization levels using a gel filtration column. The proteins were purified 
without ATP, and, therefore, they were in the monomeric form during the purified 
process. ATP was added to a final concentration of 1 mM into the concentrated protein 
samples before the samples were stored at -80°C. 100 μl of CII variants at a 
concentration of 10 μM    were incubated at 25°C for 30mins before analysis of 
hexameric formation by a  Superdex 200 10/300 GL gel filtration column with a flow 
rate of 0.8  mL/min.  CII-EE  and  CII-ET  show  37%  and  94%  hexamer,  respectively   
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Figure 17 CII ring flexibility depends on the state of phosphorylation at residues S431 
and T432 and A-loop position. A) Gel filtration profiles of isolated CII domains of wt-
CII (panel 1) and phosphomimics of SpT-CII (panel 2), pSpT-CII (panel 3), pST-CII 
(panel 4), and pSpT-CII487 and pST-CII487 (panel 5). The hexameric form of the CI 
and CII domains eluted at ~11.6 mL, whereas the monomeric form eluted at ~15.4 mL. 
In panel A5 the constructs were truncated just prior to the A-loops at residue 488, and 
eluted as monomers at 16 mL. B) – D) Selected regions from methyl-TROSY (117) 
(139) spectra of U-D, Ile-[ 1　 13CH3] labeled wt-KaiC (panel 1) and phosphomimics of 
KaiC-SpT (panel 2), KaiC-pSpT (panel 3), KaiC-pST (panel 4), and KaiC-pSpT487 
(panel 5). All panels were plotted at the same relative contour level. Gel-filtration 
experiments (not shown) indicate that these KaiC mutants did not aggregate. Red and 
blue contours indicate peaks assigned to Ile residues of the CII and CI domains of 
KaiC, respectively, whereas black contours indicate unassigned peaks. Please see Fig. 
2-8, 2-10 and appendixes for details on these assignments and experiments. 
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(Fig. 17A). In comparison, CII and CII-SE show only 14% and 0% hexamer, 
respectively. The trend of hexamerization level confirms  that  phosphorylation of  
Ser431 reduces the CII  ring flexibility  and  the induced rigidity results in the formation 
of hexamers. On the other hand, CII-EE has 63% monomer but CII-ET only has 6% 
monomer. It suggests that phosph-T432 offsets the rigidity induced by phospho-S431. 
However, CII-EE487 and CII-ET487 have 100% monomer indicates that the exposed A-
loops decrease the rigidity more than the rigidity induced by phospho-S431. Collectively, 
these gel filtration results corroborate the NMR results of KaiC variants that the 
formation of hexamer corresponds to the rigidity of the CII ring. 
 
Figure 18 Overlay of methyl-TROSY spectra of KaiC-EE (black), CI (blue, residues 
1-247), and CII-EE (red, residues 249-518). Sample conditions and NMR parameters 
are described in Table 1. These spectra were used to assign resonances to the CI and 
CII domains of full-length KaiC spectra. 
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    KaiA binding is not affected by the oligomeric state of CII domain. We also wondered 
if KaiA binds to the CII domain variants. This is to test if KaiA binding with A-loops is 
altered by the change of the flexibility of the CII ring and the oligomeric state of the CII 
ring. Thus, we prepared the same CII ring variants and they were mixed with KaiA in 
1:1 monomeric ratio at a concentration of 10 μM at 25°C for 30 mins in the presence of 
1 mM ATP. KaiC phosphorylation profile shows that KaiA enhances KaiC 
phosphorylation after 30 mins (Fig. 15). In addition, the binding between S. elongatus 
KaiA and unphosphorylated or phosphorylated KaiC is strong, The Kd is 3nM for KaiC-
EE and 32 nM for KaiC-AA (90). Therefore, if KaiA binds to CII rings, we should be 
able to see it in 30 mins incubation. The binding reactions were analyzed by using a 
Superdex 200 10/300 GL gel filtration column with a flow rate of 0.8 mL/min. Fig. 18 
showed KaiA-induced peak shifts for all CII variants mixed with KaiA. KaiA binds to 
all the monomeric wt-CII, SE-CII, and EE-CII and the hexameric EE-CII and ET-CII  
(Fig. 19). However, KaiA binding affinity to hexameric KaiC variants is higher than 
monomeric KaiC variants, as seen from the free monomeric CII peak by gel filtration. 
Indeed, the binding between KaiA  and  KaiC  phosphomimics  are  stronger  than  KaiA  
 
Figure 19 KaiA and CII binding. Gel-filtration profiles of mixtures of KaiB with CII 
(panel 1) and with phosphomimics of KaiC-SpT (panel 2), KaiC-pSpT (panel 3), and 
KaiC-pST (panel 4). The elution profiles of KaiB in each panel were from a single run. 
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 with the A-loops + tail peptides of KaiC (KaiCAL+tail) (90). S. elongatus KaiA binding 
affinity  to  KaiCAL+tail  is  170 μM  (86).  The  difference  in  binding  affinities  between  
 
(B)                                                              (C) 
 
Figure 20 Phosphorylation profiles of KaiC phosphomimics. (A) SDS-PAGE gel 
showing phosphorylation kinetics of KaiC, KaiC-AT, KaiC-SE, KaiC-SA, and KaiC-ET 
in the presence or absence of KaiA. (B) Gel densitometry analysis of KaiC in the 
presence of KaiA. (C) Gel densitometry analysis of KaiC in the absence of KaiA. See 
Materials and Methods for experimental conditions. 
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hexameric and monomeric KaiC variants is probably from differences in the local 
concentrations of available A-loops. The distribution of A-loops from momomeric KaiC 
is similar to the distribution of KaiCAL+tail in solution. Thus, the results suggests that 
KaiA binds to KaiC regardless of flexibility of the CII ring, but the binding affinity is 
different regarding to oligomeric state of KaiC. Indeed, KaiA has been found to bind to 
KaiC during the whole phosphorylation cycle (66, 70). The fact that Hayashi et al. (82) 
showed that KaiA enhances CII phosphorylation about 5% compared with full-length 
KaiC is probably due to the hexamerization of CII is only 14% based on our 
obwervation. Overall, these results indicate that KaiA binding to KaiC is not regulated 
by the flexibility of the CII ring but hexamerization of KaiC is necessary for the KaiA-
induced KaiC phosphorylation.    
    Dynamics determine the sequential order of phosphorylation. The fact that the CII 
ring is flexible during the Phosphorylation Phase prompted us to test if CII ring 
flexibility and rigidity determines the phosphorylation order of Ser431 and Thr432: 
ST?SpT?pSpT. To understand the role of dynamics in sequential phosphorylation, we 
prepared KaiC, KaiC-SE, KaiC-SA, KaiC-AT, and KaiC-ET and compared their 
phosphorylation levels in the presence and absence of KaiA (Fig. 20). All the KaiC 
variants had been preincubated at 30°C for 16h in order to reach a hypophosphorylated 
state. The concentration of KaiC variants, KaiA, and ATP were 3.5 μM, 1.2 μM, and 1 
mM, respectively. The reactions were prepared in two groups: one is with KaiA and the 
other is without KaiA. All reactions were incubated at 30°C for another 24h after a 16h 
preincubation. The aliquots were collected following the time course shown in the 
Fig.20. In the presence of KaiA, wt-KaiC, KaiC-AT, KaiC-SE, and KaiC-SA gets to 
88%, 84%, 81%, and 56% phosphorylation level, respectively. The high phosphorylation 
levels of KaiC-SE and KaiC-AT indicate that T432 tends to get phosphorylation and its 
phosphorylation can promote phosphorylation of S431. In contrast, KaiC-SA gets 
phosphorylation only to 56% in the presence of KaiA. This phenomenon can be 
explained by the flexibility of the CII ring. The flexibility of the CII ring enhances 
phosphorylation, whereas the rigidity induced by phospho-S431 promotes 
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dephosphorylation. In KaiC-SA, phospho-S431 induces rigidity, which inhibits further 
phosphorylation and results in only 56% pST. In KaiC-ET, no phosphorylation occurred 
in the presence of KaiA, suggesting that the rigidity induced by phospho-S431 inhibits 
phosphorylation at T432. On the other hand, in the absence of KaiA, wt-KaiC, KaiC-AT, 
KaiC-SE, and KaiC-SA all show no phosphorylation increments. It indicates that 
phospho-T432 is able to sustain the flexibility of the CII ring but the overall flexibility is 
not enough for KaiC-SE to phosphorylate spontaneously which strongly underlies the 
importance of KaiA. Although we do not have methyl-TROSY data for KaiC-AT, we 
believe that KaiC-AT exhibits a flexibility of the CII ring similar to those of 
hypophosphorylated wt-KaiC, KaiC-SE, and KaiC-AE. Overall, the data strongly 
suggests that T432 necessarily phosphorylates first so that the CII ring remains flexible 
enough for A-loop exposure during progressive autophosphorylation of S431 residues 
and results in the sequential order as ST ? SpT ? pSpT.   
 
2.4 Discussion 
 
Exposed A-loops and phospho-T432 are important for the KaiC Phosphorylation 
Phase. KaiA binds to KaiC on the A-loops to stimulate phosphorylation of KaiC at S431 
and T432 (85) (59). Even though no exposed A-loops in full-length KaiC structures have 
been reported, the hypothesis that A-loop exposure enhances KaiC phosphorylation has 
been supported by KaiC A-loop truncation experiments (86). KaiC497, which the tail is 
removed and mimics the buried A-loop state, and KaiC487, which the A-loops and tails 
are removed , both do not bind to KaiA but stay in the hypophosphorylated state and 
hyperphosphorylated state, respectively (86). The conclusion that A-loop position affects 
phosphorylation level is further supported by the phosphorylated level of different length 
truncations of the A-loops: KaiC496, KaiC495, and KaiC494 show increased 
phosphorylation levels compared with KaiC497 (86). Nonetheless, overlay of A-loops in 
the X-ray crystal structures of several different phosphomimics of KaiC are virtually 
identical at the quaternary level (89). The only phosphorylation-dependent structural 
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differences on overall KaiC structure are localized around the sites of phosphorylation, 
which are buried deep in the crevasses between domains of the CII ring.  
We have proposed that the A-loops of KaiC exist in equilibrium between exposed and 
buried states and KaiA stabilizes the exposed state to induce phosphorylation of KaiC 
(86). Previously, our group showed that KaiC-DT is hypophosphorylated but KaiC-
DT487 (A-loops removed) is constitutively hyperphosphorylated, which suggests that A-
loops are dominantly buried during the Dephosphorylation Phase. Although all the 
observations support our proposal, the mechanism by which the state of A-loops is 
regulated was not clear. Our study here strongly suggests that the flexibility of the CII 
ring is the key to regulate A-loops position. To prove the exposed state is dictated by the 
flexibility of the CII ring, we needed to rule out the possibility that the exposed state of 
A-loops might be pulled out by KaiA. The possibility is not likely because of two points: 
first, KaiA:KaiC complex has been found existing over the whole phosphorylation cycle 
(69, 70); second, we did not observe the increasing phosphorylation of KaiC-ET in the 
presence of KaiA (Fig. 20). If A-loops were pulled out every time when bound to KaiA, 
we should see the increasing phosphorylation level when KaiC-ET is mixed with KaiA. 
In fact, KaiA binds to hexameric CII-ET (Fig. 19) which could support KaiA binds to 
KaiC-ET but no phosphorylation occurs on KaiC-ET (Fig. 20). It indicates that KaiA 
does not pull out the A-loops of KaiC. Therefore, more likely, KaiA functions as 
stabilizing the exposed A-loops, and the exposed or buried state is controlled by KaiC 
itself. Then, the next question would be how KaiC regulates A-loop position. Removal 
of A-loops from KaiC, like KaiC487 and KaiC-DT487, always increases 
phosphorylation level; it indicates that the exposed A-loops are favored in 
phosphorylating KaiC. Therefore, the exposed A-loops are favored in the 
Phosphorylation Phase and disfavored in the Dephosphorylation Phase. If so, it is 
rational to speculate that A-loop position is under control by KaiC phosphorylation. 
However, only subtle structural differences are observed between different 
phosphorylation states of KaiC, and thus they cannot explain why A-loops prefer the 
exposed state in the Phosphorylation Phase. Nonetheless, our data clearly shows that the 
  
53
phosphorylation state of KaiC regulates the CII ring flexibility and, in turn, the 
flexibility of the CII ring controls A-loop position. Our data reveal that phospho-T432 
and phospho-S431 have opposite effects on dynamics that could separate the 
phosphorylation cycle into two dynamic phases, and A-loop position is regulated by the 
flexibility of the CII ring. 
The NMR data show that phospho-T432 does not reduce the flexibility of the CII ring 
and the exposed A-loops enhance the flexibility of the CII ring as well. Even KaiC and 
KaiC-SE exhibit flexibility, but the additional flexibility from KaiA from stabilizing the 
exposed position of the A-loops is necessary for KaiC ST?SpT?pSpT phosphorylation 
and KaiC-SE?KaiC-pSE. The results indicate both the exposed A-loops and phospho-
T432 are important for KaiC phosphorylation. The model of KaiC phosphorylation in 
the Phosphorylated Phase is proposed as three steps. First, the flexible CII ring of 
hypophosphorylated KaiC allows A-loops exposure; the additional flexibility from the 
exposed A-loops stabilized by KaiA enhances KaiC phosphorylation in the order 
ST?SpT. Second, phospho-T432 sustains the flexibility of CII ring, and with the 
additional flexibility from the exposed A-loops stabilized by KaiA, enhances KaiC 
phosphorylation in the order SpT?pSpT. Last, KaiC-pSpT transitions KaiC into the 
Dephosphorylation Phase. During this Transition Phase, KaiB recognizes the rigid KaiC 
in the hyperphosphorylated state and binds to it in preparation for the Dephosphorylation 
Phase. The Transition Phase and the Dephosphorylation Phase will be discussed in 
CHAPTER III and IV.    
Hexamerization caused by phosphorylation. KaiC functions as a hexamer induced by 
ATP (80). The double doughnut-like rings, CI and CII, share a very similar structure (73) 
and contain ATPase motifs, including Walker motifs A and B, and a pair of deduced 
catalytic carboxylate Glu residues (named CatEs) (80). The CI ring has a higher ATP 
binding affinity than the CII ring and is responsible for the hexamerization, whereas the 
CII ring is responsible for phosphorylation and stability. Although the CII domains has 
contribute to hexamerization (80), this is the first report showing that CII 
phosphorylation correlates to hexamerization of the CII ring in a stepwise mannered 
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with ATP (Fig. 17A). Previously,  mutations at the Walker A motifs of both domains 
severely suppresses the hexamerization of  KaiC, much  more so than a mutation only  at   
the CI walker A motif (80). Thus, they concluded that the CII ring also contributes to the 
hexamerization of KaiC. In addition, our data suggest that full-length KaiC 
phosphomimics do not inhibit the hexamerization. Therefore, the hexamerization ability 
of CII phosphomimics shown here not only determines the dynamic difference of the CII 
ring but also the importance of phosphorylation on hexamerization.      
Coupling of the A-loops to the phosphorylation sites. When KaiA stabilizes the 
exposed A-loops, the A-loops are not fully exposed. In contrast, KaiC487 is 
constitutively 100% phosphorylated (86). The hyperphosphorylated state of wt-KaiC is 
more similar to the phosphorylation level of KaiC494 and KaiC 496 (86). Both these two 
KaiC mutants mimic a partial A-loop exposed state. Clearly, A-loop position is coupled 
 
 
 
 
Figure 21 Inter-A-loop hydrogen bonds. Top-down view of KaiC. A) ATPs are red, 
S431 and T432 are yellow, A-loops are magenta, and the peptide linker between the CI 
and CII domains is green. Five subunits are shown as surfaces and one subunit is shown 
as a blue ribbon. B) Expansion of the A-loop region. Putative intersubunit hydrogen 
bonds involving A-loop residues are shown as green lines. A-loop exposure is expected 
to disrupt this ring of hydrogen bonds, increasing the dynamics of the CII ring. 
According to our model, the ATP molecules bound at the interfaces of the CII domains 
would then be allowed to approach S431 and T432. 
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to the phosphorylation sites. The distances between the γP of ATP and the hydroxyls of 
S431 and T432 are ≥1.6 Å beyond the minimal distance for phosphoryl transfer (Fig. 11) 
(84). Our results support the notion that exposed A-loops affect the flexibility of KaiC 
by disrupting a hydrogen bond network between CII ring subunits (Fig. 21); leading to 
disrupted interactions at the phosphorylation sites (Fig. 22). The disruption of 
interactions at the phosphorylation sites brings ATP, T432, and S431 close for 
phosphorylation. In the KaiC structure (Fig. 21B), the side-chain of the residues E487 
and T495 appears to hydrogen-bonded to each other. The side-chain of the residue R488 
also forms a hydrogen bond with the side-chain of R488 from the adjacent subunit, 
creating a ring of hydrogen bonds. It suggests that hydrogen-bond formation stabilizes 
the buried position of the A-loops. Indeed, the E487A and T495A substitution resulted in 
~100% and 80% phosphorylation of KaiC, respectively (86). In addition, A-loop 
exposure apparently disrupts interactions at the phosphorylation sites. There are at least 
three possibilities for how KaiA displacement of the A-loops increases the local 
flexibility of ATP, S431, and T432 (Fig. 22). A) A-loops exposure could disrupt 
interactions between D474’ and ATP, allowing ATP to move toward S431 and T432. B) 
Disruption of interactions between the A-loop and E444’ is expected to increase the 
flexibility of P-loop residues (e.g., the highly conserved K294’), which could increase 
the mobility of the ATP molecule. Indeed, our lab has previously shown that the E444A 
mutation results in a constitutively hyperphosphorylated KaiC variant (86). C) Others 
have shown that a G421R substitution lengthens the period to 44 h (73), and the 
structure of KaiC predicts that G421R disrupts a backbone-backbone hydrogen bond 
with S491 of the A-loop. Disruption of this hydrogen bond by A-loops exposure is 
expected to increase the dynamics of S431 and T432, thereby promoting their stochastic 
approach to the bound ATP molecule. The phosphorylation state of the G421R variant is 
not known, presently, but our model predicts that it is hyperphosphorylated. Thus, the 
exposed A-loops likely increase KaiC CII ring flexibility by disruption several 
interactions between buried A-loops and phosphorylation sites. The disruption of the 
interactions changes the flexibility of KaiC CII ring to induce autophosphorylation.  
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KaiC dynamics determines the autokinase and autophosphatase activities. KaiC is 
both an autokinase (61) and an autophosphatase (54). The equilibrium of these two 
activities is modulated by its  phosphorylation,  which  is  regulated  by  KaiA and  KaiB 
(65, 66). Previously, the A-loops have been suggested to be the switch of autokinase and 
autophosphatase activities of KaiC depending on their position (exposed or buried). 
However, we found that the flexibility of the CII ring is the switch of autokinase and 
 
Figure 22 Interactions possibly disrupted by A-loop exposure. Three of the possible 
ways the KaiA-binding site (A-loop, magenta) and the phosphorylation sites, S431 and 
T432, of KaiC are coupled. The blue and gold colors are used to indicate different 
subunits of KaiC. The green lines indicate the locations of putative hydrogen bonds. 
K294 locates in the P-loop which is responsible for the nucleotide binding.   
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autophosphatase activities. The A-loop position is epistatic to KaiC phosphorylation 
state in the control of the flexibility of the CII ring. In the Phosphorylation Phase, KaiA 
stabilizes the exposed A-loops which enhances autokinase activity. However, when 
KaiC reaches the hyperphosphorylated state, KaiC becomes rigid, resulting in A-loops 
burial, which inhibits autokinase activity. Once S431 becomes phosphorylated, the A-
loops favor the buried state, reducing CII ring flexibility. The autophosphatase activity 
becomes dominant and KaiC dephosphorylates. Overall, therefore, the autokinase 
activity is dominant when KaiC is flexible and the autophosphatase activity is dominant 
when KaiC is rigid. It is clear that the autokinase and autophosphatase activity must be 
regulated by the flexibility of the CII ring. KaiC is also an ATPase (80). This dynamic 
state of the CII ring also regulates its ATPase activity. Importantly, the ATPase activity 
has been linked to the output pathway (51) and this part will be discussed in more detail 
in CHAPTER IV. 
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CHAPTER III 
MECHANISM OF THE TRANSITION PHASE 
     
3.1 Introduction  
 
All circadian oscillator systems, including those of humans, can be described as a 
succession of phases (Fig. 23). Therefore, understanding oscillator mechanism amounts 
to understanding the transitions between phases. In the case of the KaiABC oscillator, 
The Transition Phase is marked by the formation of the KaiB:KaiC complex, as a result 
of phosphorylation at residue S431(65, 66). Yet, the transition mechanism is not known. 
Although there are low resolution electron microscopy (EM) models of this complex 
(87), they do not inform on why KaiB binds to KaiC only upon S431 phosphorylation. 
The EM data shows that KaiC, in a hyperphosphorylated state, forms a complex with 
KaiB or both KaiA and KaiB (87). KaiB forms a complex on the top of KaiC CII ring 
(Fig. 24). However, KaiC structures in different states of phosphorylation, including  
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Figure 23 KaiC phosphorylation order diagram. In our model, the Phosphorylation 
Phase is indicated as red part, the Transition Phase showed as blue and the 
Dephosphorylation Phase is green and, then, the whole cycle start anew. 
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Figure 24 Overlay of seven crystal structures of KaiC phosphoforms. (PDB ID: 
3K0A, 3K0C, 3DVL, 3K0E,  3JZM, 3K0F, and 3K09) (89). 
KaiC
KaiB
 
Figure 25 Negative-stain EM structures of KaiB and KaiC complex. (top) Two 
KaiB dimers ( redidues 8-94) from the X-ray crystal structure of ThKaiB are shown 
within the third layer of density of the KaiBC structure from (bottom). (bottom) 
Three-dimensional reconstruction of the KaiBC complex based on 7415 particle 
images processed without imposed symmetry (87).  
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those do and do not bind KaiB, are virtually identical (Fig. 25) (89). Furthermore, it is 
unknown how the KaiB:KaiC interaction during this phase creates a new site to which 
KaiA will bind in the next phase (90). Thus, my goal here is to elucidate the Transition 
Phase, which is marked by the formation of a stable KaiB:KaiC complex. Based on the 
observations that CII ring flexibility is reduced when S431 becomes phosphorylated, we 
propose that the flexibility of the CII ring plays a central role in the KaiB:KaiC complex 
formation. There are several protein systems in which protein dynamics has been 
demonstrated to play a key role in allosteric regulation of protein function (108, 132, 
133). For example, cAMP activation of a catabolite activator protein (CAP) mutant for 
DNA binding is through dynamic allostery. In this CAP mutant, cAMP fails to switch 
the DNA binding domains to the active conformation, as happens with wt-CAP, but 
activates the mutant to bind DNA with high affinity and specificity through a large 
concomitant increase in protein dynamics (i.e., entropy) (132). This example inspired  
usto think that the formation of the KaiB:KaiC complex might be very similar. One 
mutation in CAP regulates DNA binding by changing the dynamic states of CAP 
without inducing structural changes. According to our notion, phospho-S431 may 
enhance KaiB binding to KaiC by changing the dynamic state of KaiC instead of 
inducing structural changes. This idea, if true, would explain why X-ray crystal 
structures of different phosphorylated KaiC proteins are virtually identical. Our 
hypothesis is that the rigid state of KaiC as induced by phospho-S431 induces KaiB to 
form a stable complex with it as a dimer, thereby exposing a surface of KaiB previously 
hidden in its tetrameric state.  
    To test this hypothesis, first we used gel filtration chromatography to verify the 
binding between KaiB and the different phosphomimics of KaiC, which are KaiC-ST, 
KaiC-SE, KaiC-EE, and KaiC-ET. We found KaiB binds to KaiC-EE and KaiC-ET and 
this is consistent with previous observations (69, 70) that KaiB binds to KaiC in the 
Dephosphorylation Phase in which KaiC are mostly in the pSpT and pST states. In 
addition, we have known from CHAPTER I that CI ring provides the hexamerization 
ability to CII ring formation,  therefore, we are interested in if the CII ring could  provide 
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enough rigidity for itself on the binding with KaiB, thus, we prepared wt-CII, CII-SE, 
CII-EE, and CII-ET and, then, mixed with KaiB to test the binding. Moreover, we want 
to test if KaiB change its structure upon binding to KaiC since it  has  been  suggested  to  
bind to KaiC in a dimeric form different from its free tetrameric form (87). Thus, we 
prepared U-[15N,2H,12C],Ile-[δ1 13CH3]-labeled KaiB and U-[15N,2H,12C],Ile-[δ1 13CH3]-
labeled KaiC-EE and titrated them with unlabeled KaiC-EE and KaiB, respectively. 
Methyl-TROSY spectra showed that the formation of the KaiB:KaiC complex depends 
on sufficiently reduced the flexibility of the CII ring resulting from phosphorylation at 
residue S431. Nonetheless, KaiB does not form a complex with isolated CII-EE 
hexamers or CII-ET hexamers. It suggests that the CII ring by itself may not provide 
enough rigidity for KaiB recognition and, additionally, KaiB recognizes the rigidity of 
KaiC rather than phospho-S431. The NMR results revealed that KaiB undergoes a large 
conformation change upon KaiC binding, whereas the structure of KaiC does not change 
upon KaiB binding.  
 
3.2 Materials and Methods2 
 
    T. elongatus KaiB, KaiC and KaiC mutants expression and purification. The genes 
encoding KaiB and KaiC from T. elongatus were cloned into the pET28a+ vector 
(Novagen) between the NdeI and HindIII sites. The resulting plasmids were used to 
transform Escherichia coli BL21(DE3), and  the sequences were confirmed (DNA 
Sequencing Facility, University of California, Berkeley). Transformed E. coli cultures 
were incubated at 37°C until OD600 reached about 0.6; at this point, a final concentration 
of 200 μM isopropyl β-D-thiogalactopyranoside (Research Product International) was 
added for overexpression. Cells were harvested after 12 h overexpression at 25°C, and 
pellets were resuspended in 20 mM Tris-NaOH, 500 mM NaCl, pH 7.0. Cell suspensions 
were passed twice through a chilled French press cell, and lysates were clarified by 
_____________ 
2 Supplementary information of materials and methods are in the Appendixes A-F. 
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centrifugation at 20,000 x g for 60 min at 4°C. Tagged proteins were isolated on a Ni-
charged column. Proteins were buffer exchanged to 20 M Tris Base, 500 mM NaCl and 
20 mM Imidazole and 100 μl 100 μM ULP1 protease were added for SUMO-His6 tag 
removal. The cleavage reaction was carried out at 4°C for 16 h in 15 mL volume. Kai 
proteins were separated from SUMO-His6 tag protein by a second Ni-charged column 
and followed by gel filtration chromatography on a Superdex 200 HiLoad 16/60 prep 
grade column (GE Healthcare) for KaiC and a Superdex 75 HiLoad 16/60 prep grade 
column (GE Healthcare) for KaiC-CII variants and KaiB. Buffers were exchanged to 20 
mM Tris Base, 50 mM NaCl, 1 mM MgCl2, 5 mM DTT, 1 mM ATP, pH 7.0 for the 
binding assay and NMR experiments. Proteins were concentrated by Amicon Stirred 
Ultrafiltration Cell (MILLIPORE) and stored in a -80°C freezer. KaiA, KaiB, and KaiC 
did not lose function after repeated cycles of freezing and thawing. One liter LB yields ~ 
1728 nmol of KaiB, and ~ 240 nmol of KaiC and KaiC mutants. Coomassie Plus (Pierce) 
was used as a Bradford Assay reagent for protein concentration determination. For 
purification of KaiC, all the solutions were prepared with 1 mM ATP.  
    U-[15N, 2H], Ileδ1-[13C,1H]-labeled proteins (KaiB and KaiC-EE) expression and 
purification. Expression: Follow protocol A-10. Purification: Follow protocol A-11. 
Note that BioExpress (Cambridge Isotope Laboratories) was used to increase the growth 
rate of E. coli. 
ULP1 protease expression and purification. Expression: Follow protocol A-8. 
Purification: Follow protocol A-12 but stops after the elution step of 1st Ni-NTA column. 
Note that Ulp1 is not stable in buffers where NaCl is at a concentration lower than 100 
mM. For long-term storage, add equal volume of glycerol into the Ulp1 elution sample 
from Ni-NTA column and store at -80°C. Ulp1 elution sample can be diluted to a final 
concentration of 200 μM before adding glycerol. Therefore, the final Ulp1 stock (stored 
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at -80°C) will be 100 μM in the buffer of 25 mM NaH2PO4, 250 mM NaCl, 125 mM 
imidazole, 50% glycerol, pH 8.0. 
    Binding Assay. All column bindng assays including KaiC-CII alone experiments were 
carried out using a Superdex 200 10/300 GL gel filtration column (GE Healthcare). 
Ferritin (440 kDa), albumin (67 kDa), ovalbumin (43 kDa), and chymotrypsinogen A 
(25 kDa) were used as molecular mass standards.     
KaiC and KaiB binding. Recombinant KaiC and KaiB were mixed in 1:1 ratio (10 μM: 
10 μM) in 300 μl binding buffer (20 mM Tris, 50 mM NaCl, 1 mM MgCl2, 5 mM DTT, 
1 mM ATP, pH 7.0) at 25°C for 17 h. 
    KaiC-CII variants and KaiB binding. Recombinant KaiC-CII variants and KaiB were 
mixed in 1:1 ratio (10 μM: 10 μM) in 100 μl binding buffer (20 mM Tris, 50 mM NaCl, 
1 mM MgCl2, 5 mM DTT, 1 mM ATP, pH 7.0) at 25°C for 17 h.  
Kinetics of KaiC-EE vs KaiC-ET. Recombinant KaiC and KaiB were mixed in 1:3 
ratio (10 μM: 30 μM) in 100 μl binding buffer (20 mM Tris, 50 mM NaCl, 1 mM MgCl2, 
5 mM DTT, 1 mM ATP, pH 7.0) at 25°C. 
NMR Sample Preparation and Spectroscopy. NMR sample preparation: Follow 
protocol C-1. NMR sample information: Please see Table 2. NMR spectroscopy: Follow 
Protocol C-2.  
 
3.3 Results 
 
KaiB recognizes the rigid state of phospho-S431-KaiC. KaiB antagonizes KaiA 
stimulation of KaiC phosphorylation but only after KaiC reaches a hyperphosphorylated 
state (63) (140). KaiB forms a complex with hyperphosphorylated KaiC, marking the 
transition from the Phosphorylation to Dephosphorylation Phase. We have shown that 
KaiC exhibits two major dynamic states, depending on its state of phosphorylation. To 
test if these dynamic features are the key to induce KaiB recognition on KaiC, we 
prepared KaiC, KaiC-SE, KaiC-EE, and KaiC-ET and mixed them with KaiB in a 1:1 
monomeric ratio. The concentrations of KaiC variants and KaiB were 10 μM each in 
  
 
Table 2 NMR Sample Condition and Experiment for CHAPTER III 
Sample Experiment Sample detail Experiment detail 
KaiB 
U-[15N, 2H]-Ileδ1-[13C, 1H]-
AMA-KaiB 
Methyl-TROSY Concentration:  20 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM 
MgCl2, 5 mM DTT, 1 mM ATP, pH 7.0, 10 
μM DSS, 0.02% NaN3, 99.96% D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=20 
40 °C 
KaiC 
U-[15N, 2H]-Ileδ1-[13C, 1H]-
FLAG-KaiC-EE 
Methyl-TROSY Concentration:  16 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM 
MgCl2, 5 mM DTT, 1 mM ATP, pH 7.0, 10 
μM DSS, 0.02% NaN3, 99.96% D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=128 
40 °C 
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300 μl. The reactions were incubated at 25°C for 17h. The final reactions were analyzed 
by Superdex 200 10/300 GL gel filtration chromatography, with a flow rate of 0.8 
mL/min. As shown in CHAPTER I, the CII ring of KaiC is flexible during the 
Phosphorylation Phase and rigid during the Dephosphorylation Phase. We found that 
KaiB binds to KaiC-EE and KaiC-ET, which are representative of KaiC in the 
Dephosphorylation Phase, but not KaiC-ST and KaiC-SE (Fig. 26). The data are 
consistent with earlier observations that the KaiB:KaiC complex is found during the 
Dephosphorylation Phase but not the Phosphorylation Phase (69, 70). To test whether 
KaiB recognizes the rigidity of KaiC or phospho-S431 directly, we prepared KaiC-
EE487, which has been shown to be flexible, and, mixed it with KaiB in 1:1 monomeric 
reaction at a concentration of 10 μM in 300 μl at 25°C for 17h with 1 mM ATP. The 
final reactions were analyzed by Superdex 200 10/300 GL gel filtration column with a 
flow rate of 0.8 mL/min. We found that KaiB does not bind to KaiC-EE487 (Fig. 26). 
The result suggests that KaiB recognizes the rigidity of KaiC but not phospho-S431 
directly. Indeed, KaiB has been shown to interact with KaiC on the top of the CII ring 
(70) and not at the phosphorylation site, which is buried inside the interface between two 
KaiC subunits (60).   
Next, we were interested in the binding between KaiB and CII ring variants. KaiC 
hexamerization depends on ATP (80). The CI domains contributes to the hexamerization 
of KaiC significantly more than the CII domains (80, 82). The CI ring serve as a 
platform, whereas the CII ring is the functional center (82). In CHAPTER I, we showed 
that the CI ring provides hexamerization ability for CII ring formation. Here, we 
wondered whether the hexamerization scaffold from CI ring contributes to the rigidity of 
the CII ring. The binding between KaiB and CII variants would inform on the function 
of CI ring on CII ring rigidity. We purified CII variants without ATP, and, thus, they 
were in the monomeric form during the purification process. The  concentration of  KaiB   
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and CII variants were mixed in 1:1 monomeric ratio, 10 μM:10 μM, in 100 μl at 25°C 
for 17h with 1 mM ATP. The reactions were analyzed by a Superdex 200 10/300 GL gel 
filtration column with a flow rate of 0.8 mL/min. Interestingly, KaiB does not form a  
 
Figure 26 KaiB-KaiC binding experiments. Gel-filtration profiles of mixtures of KaiB 
with wt-KaiC (panel 1) and with phosphomimics of KaiC-SpT (panel 2), KaiC-pSpT 
(panel 3), KaiC-pST (panel 4), and KaiC-pSpT487 (panel 5). The elution profiles of KaiB 
in each panel were from a single run. 
 
 
 
Figure 27 KaiB-CII binding experiments. KaiB and CII variants binding. Gel-filtration 
profiles of mixtures of KaiA with CII (panel 1) and with phosphomimics of KaiC-SpT 
(panel 2), KaiC-pSpT (panel 3), and KaiC-pST (panel 4).  The elution profiles of KaiB in 
each panel were from a single run. 
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complex with either monomeric wt-CII, CII-SE, CII-EE, and CII-ET or hexameric CII-
EE and CII-ET (Fig. 27). The results show that KaiB does not interact with either 
monomeric CII domains or hexameric CII rings, suggesting that CII ring rigidity induced  
 
Figure 28 KaiB + KaiC binding kinetics. (A) Time course gel filtration 
chromatography of KaiB binding to KaiC-EE (first row) and KaiC-ET (bottom row). 
The chromatograms in the right column are from an expanded region of the 
chromatograms in the left column. Molecular weight markers in kDa are indicated on 
top of left panels. 
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by phospho-S431 is not sufficient for KaiB recognition, but needs further rigidification 
provided by the presence of the CI ring.    
KaiB binding rate with KaiC mutants. Since we concluded in CHAPTER I that 
phospho-S431 induces CII ring rigidity and phospho-T432 offsets the rigidity, we were 
interested whether phospho-T432 decreases the binding kinetics between KaiB and KaiC. 
We prepared KaiC-EE, and KaiC-ET and mixed them separately with KaiB in 1:1 
monomeric ratios The concentrations of the KaiC variants and KaiB were 10 μM each in 
100 μl. The reactions were incubated at 25°C and the mixtures were prepared 
immediately before gel filtration chromatography. We analyzed time points at 0, 1, 3, 5, 
7, 15 h. The reactions were analyzed by Superdex 200 10/300 GL gel filtration column 
with flow rate of 0.8 mL/min at real time. The results show that KaiB binds to KaiC-ET 
faster than KaiC-EE (Fig. 28), suggesting that the reduced rigidity of KaiC-pSpT relative 
to KaiC-pST slows the rate of KaiB:KaiC complex formation.        
    A-loop position affects the rigidity of KaiC. Here, we provide direct evidence that 
exposed A-loops break the phospho-S431 induced rigidity of the CII ring, corroborating 
indirect evidence that the rigidity of the CII ring requires that the A-loops are in their 
buried position. My objective was to elucidate how phosphorylation and A-loop position 
modulate CII ring flexibility. We compared CII-EE487 and CII-ET487 to CII-EE and 
 
Figure 29 Gel filtration chromatography of CII variants. Hexamerization of CII variants. 
Gel-filtration profiles of CII (panel 1) and phosphomimics of SpT-KaiC (panel 2), 
pSpT-KaiC and pSpT-KaiC487 (panel 3), and pST-KaiC and pST-KaiC487 (panel 4). 
The elution profiles of KaiB in each panel were from a single run. 
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CII-ET, respectively, by gel filtration chromatography to determine the role of the A-
loops CII ring formation. Proteins were purified without ATP, and, therefore, were in the 
monomeric. We added ATP to a final concentration of 1 mM into the protein samples 
before storing at -80°C. We prepared CII variants at 10 μM in 100 μl and incubated 
them 25°C for 30 mins. The reactions were analyzed by a Superdex 200 10/300 GL gel 
filtration chromatography with a flow rate of 0.8 mL/min. Unlike CII-EE and CII-ET, 
CII-EE487 and CII-ET487 are 100% monomeric even in the presence of 1 mM ATP 
(Fig. 29, panel 3 and 4). Phospho-S431 induces the rigidity of CII-EE and CII-ET, as 
indicated by the hexamerization of CII-EE and CII-EE. However, removal of the A-
loops in CII-EE487 and CII-ET487 abolishes the hexamerization. These observations 
strongly suggest that the A-loops are in their buried position during the 
Dephosphorylation Phase to preserve CII ring rigidity.  
 
Figure 30 KaiB conformational changes upon KaiC binding. A) Methyl-TROSY 
spectra of the U-D, Ile-[δ1 13CH3] labeled KaiC-pSpT phosphomimic free (black 
contours) and bound (red contours) to unlabeled KaiB. B) Methyl-TROSY spectra of 
U-D, Ile-[δ 1 13CH3] labeled KaiB free (black contours) and bound (red contours) to the 
unlabeled KaiC-pSpT phosphomimic.  
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    KaiB undergoes a conformational changes upon binding to KaiC. To further 
understand the interaction between KaiB and KaiC, we made U-[2H,15N], Ile-[δ1 13CH3]-
labeled KaiC-EE and  U-[2H,15N], Ile-[δ1 13CH3]-labeled KaiB following the protocols 
described in the materials and methods section. NMR samples were prepared by mixing 
either labeled KaiC-EE with unlabeled KaiB or unlabeled KaiC-EE with labeled KaiB at 
a monomer ratio of 3:2. Unlabeled KaiB and labeled KaiC were mixed in the 
concentration of 15 μM and 10 μM, respectively. Labeled KaiB and unlabeled KaiC 
were in 20 μM, and 30 μM, respectively. Both spectra were compared with the free form 
of U-[2H,15N], Ile-[δ1 13CH3]-labeled KaiC-EE and  U-[2H,15N], Ile-[δ1 13CH3]-labeled 
KaiB. Methyl-TROSY spectra were obtained at 40°C in a 600 MHz NMR spectrometer 
with a cryogenically cooled probe-head for 24 h. Fig. 30 shows that KaiB binds to U-
[2H,15N], Ile-[δ1 13CH3]-labeled EE-KaiC and without inducing chemical shift changes. 
In contrast, spectra of the free and bound forms of U-[2H,15N], Ile-[δ1 13CH3]-labeled 
KaiB are strikingly different, indicating dramatic conformational changes in KaiB upon 
binding to KaiC. The number of peaks of KaiB is reduced from 14 to 7. KaiB contains 7 
Ile, therefore, the reduced number of peaks suggests that KaiB binds to KaiC as a dimer 
rather than as the asymmetric KaiB tetramer. Taken together, the results suggest the 
KaiB undergoes structural changes upon binding, whereas KaiC remains the same. This 
also suggests that KaiC recruits KaiB through a dynamics-driven mechanism.  
                                                                                                                                                                           
3.4 Discussion 
 
Phospho-S431 plays a key role for the Dephosphorylation Phase. Phpho-S431 has 
been proposed to switch KaiC from an autokinase to an autophosphatase, as well as 
mediate association among the Kai proteins (65, 69, 70). KaiB specifically recognizes 
and binds to KaiC when S431 becomes phosphorylated, marking the transition from the 
Phosphorylation Phase to the Dephosphorylation Phase. KaiB not only forms a complex 
with KaiC but also recruits KaiA to the KaiB:KaiC complex. The concentrations of 
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KaiB:KaiC and KaiCB(A) complexes closely follow the abundance of KaiC-pST. 
Therefore, it has been suggested that phospho-S431 induces a conformational change in 
KaiC that is recognized by KaiB (65, 69, 70). However, the hypothesis seemingly 
conflicts with the fact that the phosphoforms of KaiC that do and do not bind KaiB have 
the same structure. In this study, our data strongly suggest that the selectivity of 
molecular recognition is based on differences in protein dynamics rather than structures.  
KaiB recognizes both KaiC-EE and KaiC-ET but exhibits different binding rates (Fig. 
28). The finding that KaiB binds to KaiC-ET faster than KaiC-EE verified our 
speculation that KaiB’s affinity for KaiC depends on the extent of KaiC rigidity. Our 
model is also supported by the NMR spectra of KaiC-EE and KaiC-ET (Fig. 17). Both 
spectra indicate greater rigidity relative to KaiC and KaiC-SE, but they also reveal that 
KaiC-EE is less rigid than KaiC-ET (Fig. 17C). In wild-type KaiABC oscillator reaction, 
the quantity of KaiB:KaiC complex and KaiCB(A) complex follows a rhythmic 
abundance of KaiC-pST, even though the accumulation of KaiB:KaiC complex starts 
earlier than the accumulation KaiCB(A) complex (69, 70). Why does the accumulation 
of either KaiB:KaiC complex or KaiCB(A) complex not follow the rhythmic abundance 
of KaiC-pSpT? This question can be answered in two ways: 1) KaiB and KaiC binding 
is a slow process and, 2) dephosphorylation is a continuous progress. KaiB mainly acts 
to inhibit KaiA function instead of dephosphorylating KaiC. Indeed, KaiC 
dephosphorylates. Therefore, while KaiB binds slowly to KaiC-pSpT, dephosphorylation 
to KaiC-pST is taking place simultaneously. Thus, formation of KaiB:KaiC complexes 
begins upon appearance of the KaiC-pSpT state. During accumulation of the KaiB:KaiC 
complex, pSpT-KaiC begins dephosphorylating to KaiC-pST. The KaiB:KaiC 
complexes recruit KaiA resulting an accumulation of KaiCB(A) complex. When 
KaiB:KaiC complex binds KaiA, KaiA function is inhibited leading to KaiC 
dephosphorylation. Once phospho-S431 dephosphorylates, the flexibility of the CII ring 
increases, causing the KaiCB(A) complex to dissociate, restarting the cycle anew.           
The CI ring and buried A-loops contribute to the rigidity of KaiC. In wild-type KaiC, 
phospho-S431 has been shown to dominate CII ring rigidity (see CHAPTER I). 
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However, the CI ring and the buried A-loops also affect the rigidity of CII ring (Fig. 27 
and 29). Although phospho-S431 induces the hexamerization of the CII ring (Fig. 17A) 
and the rigidity is not enough for KaiB binding without the CI ring (Fig. 27), and 
hexamerization of the CII ring is abolished without the buried A-loops (Fig. 29). Even 
though, in the latter case, full-length KaiC-EE487 is a hexamer, KaiB still does not bind 
to it (Fig. 26). Therefore, the CI ring and the buried A-loops are both important in 
regulating the rigidity of the CII ring. Thus, disruption of the CI ring, A-loop exposure, 
or dephosphorylation at S431 abolishes CII ring rigidity. Since the CI ring affects the 
rigidity of the CII ring, there is a cross-talk between them. This CII-CI communication 
may explain why ATPase activity of the CI ring is also affected by the phosphorylation 
state of the CII ring. Interestingly, a hyperphosphorylated state of KaiC, KaiC489, is 
able to form a complex with KaiB (90) which is different from our results showing that 
hyperphosphorylated KaiC487 fails to bind to KaiB. The A-loops + Tail are removed 
from both mutants except KaiC489 retains the first three residues from the A-loop. The 
missing A-loop after residue 489 induces KaiC phosphorylation. The difference between 
KaiB:KaiC487 and KaiB:KaiC489 interactions could be due to the respective absence 
and presence of residue R488, which forms a ring of hydrogen bonds between adjacent 
R488 side chains (Fig. 21). We speculate that this ring rigidifying the top of the CII ring 
enough for KaiB recognition. Notably, KaiB:KaiC489 complex formation was much 
slower than with KaiC-EE, a hyperphosphorylated KaiC phosphomimic (90). Therefore, 
a reasonable explanation for the three different binding rates between KaiB and KaiC 
variants is that the flexibility of CII ring is different in each variant. With the intact full 
length KaiC, KaiC-EE definitely is more rigid than KaiC489 and KaiC487. In KaiC489, 
both phospho-S431 and hydrogen bonds network from the remaining A-loop residues 
provide enough rigidity for KaiB binding. In contrast, KaiC487 has very flexible CII 
ring, preventing KaiB binding. Overall, the data presented here supports the model that 
the phosphorylation state of KaiC, A-loop position, and CI-CII communication are key 
determinants of the flexibility of the CII ring. Moreover, this flexibility dictates rhythmic 
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associations among the Kai proteins that are critical for the 24h rhythm of the KaiABC 
oscillator.   
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CHAPTER IV 
MECHANISM OF THE DEPHOSPHORYLATION PHASE 
     
4.1 Introduction  
 
Circadian oscillators can be described as a succession of phases, which must be 
prohibited from interfering with each other (Fig. 31). The Dephosphorylation Phase 
occurs by prohibiting KaiA from binding to the A-loops of KaiC, which is critical for 
KaiC to dephosphorylate (86). Although it is known that KaiB prevents KaiA from 
stimulating KaiC phosphorylation during this phase (65, 86, 141) and there are low 
resolution electron microscopy (EM) models of KaiCB(A) complex observed in the 
Dephosphorylation Phase, the central problem of how it is achieved has not been solved. 
There are two questions we want to answer in the Dephosphorylation Phase: first, how 
KaiB interacts with KaiA to inhibit KaiA function; second, what governs the ordered 
dephosphorylation pSpT→pST→ST. KaiB is a tetramer and KaiA is a dimer (Fig. 32). 
The weak interaction between KaiA and KaiB is greatly enhanced in the presence of 
KaiC as studied by yeast two-hybrid system and immunoblotting (142). Indeed, by 
electron microscopy, KaiA and KaiB were found together only in KaiCB(A) complexes 
(70). In 2010, the Ishiura group observed direct KaiA and KaiB interactions between 
MTSSL spin labeled KaiBT64C and KaiAC (residues 174 to 283) by electron spin 
resonance (ESR) spectroscopy (143), even though the interaction was too weak for 
detection by surface plasmon resonance spectroscopy. Thus, in the absence of KaiC, the 
KaiA-KaiB interaction is very weak. The time constant between MTSL-labeled 
KaiBT64C and KaiA is 86.2 ± 13.7 (min). ESR experiments suggested that residue T64 of 
KaiB is located near the KaiA-binding site and one subunit of KaiBT64C binds to one 
subunit of KaiAc. However, direct KaiA-KaiB contacts have not been identified, leaving 
the binding interface poorly delineated (143).  
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Since KaiC flexibility dictates the ordered pattern of phosphorylation, we also wanted 
to address whether flexibility also drives the ordered pattern of dephosphorylation, pSpT 
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Figure 31 KaiC phosphorylation order diagram. In our model, the Phosphorylation 
Phase is indicated as red part, the Transition Phase showed as blue and the 
Dephosphorylation Phase is green and whole cycle start anew. 
 
 
 
Figure 32 X-ray crystal structure of KaiA and KaiB. (A) X-ray crystal structure of KaiA 
(71). KaiA showed as a domain-swapped dimer and both subunits are in gray. (B) X-ray 
crystal structure of KaiB (144). KaiB showed as a tetramer and each color indicates a 
dimer.  
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→ pST → ST. Therefore, my goal here is to establish the role of dynamics in regulating 
KaiB-mediated dephosphorylation of KaiC. Success here would also provide insight into 
how the opposite phases of phosphorylation and dephosphorylation are prevented from 
interfering each other. KaiA is recruited away from its A-loops binding site on KaiC by 
KaiB during the Dephosphorylation Phase (90). Without KaiA binding, the A-loops 
favor their buried position, thereby promoting KaiC dephosphorylation. My hypothesis 
is that large conformational distortions in KaiB, induced in the KaiCB(A) complex, 
enhances the interaction between KaiA and KaiB (86). To test this hypothesis, we 
titrated 15N-labeled KaiA truncation mutants with KaiB:KaiC-EE497 complex and 
obtained HSQC spectra. Our results indicated that it is the linker region of KaiA 
(residues 130 to 180) that binds to the KaiB:KaiC complex during the 
Dephosphorylation Phase. The large conformational change of KaiB upon binding to 
KaiC also explains why the direct interaction between KaiA and KaiB in the absence of 
KaiC is weak. Moreover, the fact that KaiA binds to KaiB:KaiC-EE497, but does not 
bind to KaiC-EE497 in the absence of KaiB, suggests that KaiA binds directly to KaiB 
instead of KaiC. Thus, the KaiB:KaiC complex creates a new binding site for inhibiting 
KaiA function.  
In addition to the timing mechanism of Kai-based oscillator is solved, one other 
important question is how the temporal information is transduced from oscillator to 
downstream clock-controlled behavior such as genome-wide expression. A yeast-two 
hybrid screen identified a histidine kinase protein, SasA, which physically interacts with 
KaiC (48). In vivo, KaiA, KaiB, KaiC and SasA interact with each other during 
(subjective) night and dissociate from each other during (subjective) day (145). 
Disruption of the sasA gene lowers kaiBC expression, reduces the amplitude of kai gene 
expression rhythms, shortens the free-running period length, and changes the expression 
amplitudes and periods of all clock-controlled genes  (48). In addition, the sasA-null 
strain does not abolish circadian rhythms completely (48), in contrast to disruption of 
any kai gene (53). Overall, these data identify SasA as a component of a circadian output 
pathway, acting through direct interactions with KaiC. RpaA, a potential DNA-binding 
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protein, is the cognate response regulator of SasA, and together they form a two-
component signal transduction pathway (49). SasA binds to KaiC mainly in the 
(subjective) night when KaiC is phosphorylated, which stimulates autophosphorylation 
of SasA at a conserved histidyl residue. Then, the phosphate group is transferred from 
SasA to an invariant aspartyl residue located in the receiver domain of RpaA, which 
supposedly activates the effector domain for DNA binding (49). Thus, the SasA-RpaA 
two-component regulatory system transmits temporal information from the circadian 
oscillator to clock-controlled genes (49). The system also governs the gating of cell 
division, which has been shown to be regulated by the ATPase activity of KaiC. 
Therefore, understanding the regulation of SasA activity by KaiC will reveal the 
mechanism of a critical output pathway. We found that SasA specifically binds to the CI 
ring of KaiC-EE and the flexibility of the CII ring changes during the KaiC 
phosphorylation cycle, giving rise to ATPase rhythms, mainly in the CI ring. 
Specifically, the CII ring rhythmically suppresses the ATPase activity of the CI ring 
when it becomes rigid upon phosphorylation of residue S431. We speculate that 
rhythmic ATPase activity, therefore, regulates the SasA-RpaA signal transduction 
pathway.      
 
4.2 Materials and Methods3 
 
    T. elongatus Kai proteins and KaiC mutants expression and purification. The genes 
encoding all Kai proteins from T. elongatus were cloned into the pET28a+ vector 
(Novagen) between the NdeI and HindIII sites. The resulting plasmids were used to 
transform Escherichia coli BL21(DE3), and  the sequences were confirmed (DNA 
Sequencing Facility, University of California, Berkeley). Transformed E. coli cultures 
were incubated at 37°C until OD600 reached about 0.6; at this point, a final concentration 
of 200 μM isopropyl β-D-thiogalactopyranoside (Research Product International) was 
_____________ 
3 Supplementary information of materials and methods are in the Appendixes A-F.  
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added for overexpression. Cells were harvested after 12 h overexpression at 25°C, and 
pellets were resuspended in 20 mM Tris-NaOH, 500 mM NaCl, pH 7.0. Cell suspensions 
were passed twice through a chilled French press cell, and lysates were clarified by 
centrifugation at 20,000 x g for 60 min at 4°C. Tagged proteins were isolated on a Ni-
charged column. Proteins were buffer exchanged to 20 M Tris Base, 500 mM NaCl and 
20 mM Imidazole and 100 μl 100 μM ULP1 protease were added for SUMO-His6 tag 
removal. The cleavage reaction was carried out at 4°C for 16 h in 15 mL volume. Kai 
proteins were separated from SUMO-His6 tag protein by a second Ni-charged column 
and followed by gel filtration chromatography on a Superdex 200 HiLoad 16/60 prep 
grade column (GE Healthcare) for KaiC and KaiC mutants and a Superdex 75 HiLoad 
16/60 prep grade column (GE Healthcare) for KaiC-CII variants, KaiB, KaiA, and SasA-
N. Buffers were exchanged to 20 mM Tris Base, 50 mM NaCl, 1 mM MgCl2, 5 mM 
DTT, 1 mM ATP, pH 7.0 for the binding assay and NMR experiments. Proteins were 
concentrated by Amicon Stirred Ultrafiltration Cell (MILLIPORE) and stored in a -80°C 
freezer. KaiA, KaiB, and KaiC did not lose function after repeated cycles of freezing and 
thawing. One liter LB yields ~ 440 nmol of KaiA, ~ 1728 nmol of KaiB, and ~ 240 nmol 
of KaiC and KaiC mutants. Coomassie Plus (Pierce) was used as a Bradford Assay 
reagent for protein concentration determination. For purification of KaiC, all the 
solutions were prepared with 1 mM ATP.  
    Expression of 15N-labeled proteins. The plasmid encoding the gene of interest was 
transformed into BL21 (DE3) E. coli cells. Cells harboring the plasmid (or such glycerol 
stocks) were grown in M9 minimal medium (Appendix D) supplemented with 
appropriate antibiotics at 37°C until an OD600 of ~0.6. Note that M9 minimal medium 
contains 15N-NH4Cl and D-glucose as the sole nitrogen and carbon resource, 
respectively. Protein expression was induced by adding IPTG to a final concentration of 
0.2 mM. Protein induction period is about 12 h at 25°C. Expression: Follow protocol on 
A-9. Purification: Follow protocol on appendix A-12. 
ULP1 protease expression and purification. Expression: Follow protocol A-8. 
Purification: Follow protocol A-12 but stops after the elution step of 1st Ni-NTA column. 
  
79
Note that Ulp1 is not stable in buffers where NaCl is at a concentration lower than 100 
mM. For long-term storage, add equal volume of glycerol into the Ulp1 elution sample 
from Ni-NTA column and store at -80°C. Ulp1 elution sample can be diluted to a final 
concentration of 200 μM before adding glycerol. Therefore, the final Ulp1 stock (stored 
at -80°C) will be 100 μM in the buffer of 25 mM NaH2PO4, 250 mM NaCl, 125 mM 
imidazole, 50% glycerol, pH 8.0. 
    Binding Assay. All column bindng assays including KaiC-CII alone experiments were 
carried out using a Superdex 200 10/300 GL gel filtration column (GE Healthcare). 
Ferritin (440 kDa), albumin (67 kDa), ovalbumin (43 kDa), and chymotrypsinogen A 
(25 kDa) were used as molecular mass markers. 
KaiC-A, KaiB, KaiC-EE, and KaiC-EE497 binding. Recombinant KaiC-EE or KaiC-
EE497 and KaiB were mixed in 1:1 ratio (10 μM: 10 μM) in 300 μl binding buffer (20 
mM Tris, 50 mM NaCl, 1 mM MgCl2, 5 mM DTT, 1 mM ATP, pH 7.0) at 25°C for 17 h. 
KaiA of the final concentration 10 μM was added into the reaction and incubated for 
another 6 hours. 
KaiC-CII and KaiC-CI binding. Recombinant CII and CI were mixed in a 1:1 molar 
ratio (final concentration:10 μM: 10 μM ) in 100 μl binding buffer (20 mM Tris, 50 mM 
NaCl, 1 mM MgCl2, 5 mM DTT, 1 mM ATP, pH 7.0) at 25°C about 0.5 h. 
    NMR Sample Preparation and Spectroscopy. NMR sample preparation: Follow 
protocol C-1. NMR sample information: Please see Table 3. NMR spectroscopy: Follow 
Protocol C-2.  
 
4.3 Results 
 
    KaiB recruits KaiA away from A-loops to initiate Dephosphorylation Phase. The 
formation of the KaiCB(A) complex, in which KaiB hinders KaiA from up-regulating 
the autokinase activity of KaiC, initiates the Dephosphorylation Phase of the 
phosphorylation cycle of KaiC. How does KaiB antagonize KaiA? Previously, we 
  
Table 3 NMR Sample Condition and Experiment for CHAPTER IV 
Sample Experiment Sample detail Experiment detail 
KaiA 
N15-labeled KaiA-1-129 [1H, 15N-HSQC] Concentration: 40 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM MgCl2, 
5 mM DTT, 1 mM ATP, pH 7.0, 10 μM DSS, 
0.02% NaN3, 95%H2O/5%D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=20 
40 °C 
N15-labeled KaiA-1-129 
+FLAG-KaiC-EE-1-497 
+AMA-KaiB 
[1H, 15N-HSQC] Concentration: 40 μM: 60 μM: 40 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM MgCl2, 
5 mM DTT, 1 mM ATP, pH 7.0, 10 μM DSS, 
0.02% NaN3, 95%H2O/5%D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=20 
40 °C 
N15-labeled KaiA-130-283 [1H, 15N-HSQC] Concentration: 40 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM MgCl2, 
5 mM DTT, 1 mM ATP, pH 7.0, 10 μM DSS, 
0.02% NaN3, 95%H2O/5%D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=20 
40 °C 
N15-labeled KaiA-130-283 
+FLAG-KaiC-EE-1-497 
+AMA-KaiB 
[1H, 15N-HSQC] Concentration: 40 μM: 60 μM: 40 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM MgCl2, 
5 mM DTT, 1 mM ATP, pH 7.0, 10 μM DSS, 
0.02% NaN3, 95%H2O/5%D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=20 
40 °C 
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Table 3 continued 
Sample Experiment Sample detail Experiment detail 
N15-labeled KaiA-180-283 [1H, 15N-HSQC] Concentration: 40 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM MgCl2, 
5 mM DTT, 1 mM ATP, pH 7.0, 10 μM DSS, 
0.02% NaN3, 95%H2O/5%D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=20 
40 °C 
N15-labeled KaiA-180-283 
+FLAG-KaiC-EE-1-497 
+AMA-KaiB 
[1H, 15N-HSQC] Concentration: 40 μM: 60 μM: 40 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM MgCl2, 
5 mM DTT, 1 mM ATP, pH 7.0, 10 μM DSS, 
0.02% NaN3, 95%H2O/5%D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=20 
40 °C 
SasA 
N15-labeled SasA-1-107 [1H, 15N-HSQC] Concentration: 19 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM MgCl2, 
5 mM DTT, 1 mM ATP, pH 7.0, 10 μM DSS, 
0.02% NaN3, 95%H2O/5%D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=16 
25 °C 
N15-labeled SasA-1-107 
+ 
FLAG-KaiC-EE 
[1H, 15N-HSQC] Concentration: 19 μM: 40 μM 
Buffer: 20 mM Tris, 50 mM NaCl, 1 mM MgCl2, 
5 mM DTT, 1 mM ATP, pH 7.0, 10 μM DSS, 
0.02% NaN3, 95%H2O/5%D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=16 
25 °C 
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Table 3 continued 
Sample Experiment Sample detail Experiment detail 
N15-labeled SasA-1-107 [1H, 15N-HSQC] Concentration:  19 μM 
Buffer: 20 mM Tris, 1 mM MgCl2, 1 mM ATP, 5 
mM DTT, pH 8.0, 10 μM DSS, 0.02% NaN3, 
95%H2O/5%D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=16 
25 °C 
N15-labeled SasA-1-107 
+ 
KaiC-CII-258-518-S258C-
EE-FLAG 
[1H, 15N-HSQC] Concentration:  19 μM: 19 μM 
Buffer: 20 mM Tris, 1 mM MgCl2, 1 mM ATP, 5 
mM DTT, pH 8.0, 10 μM DSS, 0.02% NaN3, 
95%H2O/5%D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=16 
25 °C 
N15-labeled SasA-1-107 [1H, 15N-HSQC] Concentration:  19 μM 
Buffer: 1 mM Tris, 18 mM HEPES, 16 mM NaCl, 
pH 7.0, 10 μM DSS, 0.02% NaN3, 
95%H2O/5%D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=16 
25 °C 
N15-labeled SasA-1-107 
+ 
KaiC-CI-1-247 
[1H, 15N-HSQC] Concentration:  19 μM: 12 μM  
Buffer: 1 mM Tris, 18 mM HEPES, 16 mM NaCl, 
pH 7.0, 10 μM DSS, 0.02% NaN3, 
95%H2O/5%D2O 
Volume: ~300 μl 
Tube: shaped tube 
NS=16 
25 °C 
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showed that KaiA binds to the A-loops of KaiC. Recently, it was shown that KaiA binds 
to the KaiB:KaiC complex even with most of the A-loops of KaiC truncated (90). Thus,  
it seems plausible that the key to answer how KaiA is inactivated by KaiB lies in that 
KaiA is apparently recruited away from the A-loop binding site to a new binding site 
formed on the KaiB:KaiC complex. To test this idea, we used KaiC-EE497, which does 
not bind to KaiA (86). We prepared KaiA, KaiB, KaiC-EE and KaiC-EE497 proteins as 
described in the materials and methods section. KaiA, KaiB, and KaiC-EE or KaiC-
EE497 with mixed in 1:1:1 monomeric ratio with 10 μM in 300 μl at 25°C for 17 h in 
the presence of 1 mM ATP. The reactions were then analyzed by a Superdex 200 10/300 
GL gel filtration column with a flow rate of 0.8 mL/min. Fig. 33  shows that KaiA binds 
 
 
 
 
Figure 33 Gel filfiltration chromatography showing the KaiABC-EE497 complex 
formation. KaiC-EE full-length serves as a binding control in the presence of KaiA 
(panel 1) or of KaiA and KaiB (panel 3). The binding between KaiC-EE497, which 
lacks major part of KaiA binding sites, and KaiA (panel 2) or KaiA and KaiB (panel 4). 
Arrows in the left two panels indicate free KaiC or KaiC-EE497 (blue peak) and 
KaiC+KaiA or KaiC-EE497+KaiA (black peak). Arrows in the right two panels 
indicate free KaiC or KaiC-EE497 (blue peak) and KaiC+KaiA+KaiB or KaiC-
EE497+KaiA+KaiB (black peak). Peaks shaded contain no proteins. 
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to both KaiB:KaiC-EE and KaiB:KaiC-EE497 complexes, but not to KaiC-EE497 in the 
absence of KaiB. In CHAPTER III, fig. 30 shows that KaiB undergoes a large 
conformational changes upon KaiC binding. These results suggest that there is a new site 
on KaiB:KaiC-EE497 for KaiA binding. The newly created binding site is most likely on 
KaiB as its conformation changes dramatically upon binding to KaiC-EE497 (70). The 
KaiB:KaiC-EE497 was used by NMR to mapping the binding site on KaiA for the 
KaiB:KaiC-EE497 complex. To map KaiA and KaiB interacting surface, we made three 
different 15N-labeled truncation mutants of KaiA, which are 15N-KaiAN129 (N-terminal 
domain), 15N-KaiA130C (linker region and C-terminal domain), and 15N-KaiA180C (C-
terminal domain). These 15N-labeled KaiA proteins were mixed with unlabeled 
KaiB:KaiC-EE497 in 2:2:3 (monomer) ratio, with the  final concentrations of 40, 40, and 
60 μM,respectively. The unlabeled KaiB:KaiC-EE497 complex was preincubated at 25 
°C for 17 h. Then, 15N-KaiA180C, 15N-KaiA130C, and 15N-KaiAN129 were mixed with 
unlabeled KaiB:KaiC-EE497 complexes before collecting heteronuclear single quantum 
coherence (HSQC) spectra at 25°C for 3.5 h, 5.5 h, and 7.5 h, respectively. HSQC 
spectra of free 15N-KaiAN129, 15N-KaiA130C, and 15N-KaiA180C collected at 40 °C for 
2 h are well-dispersed. We reasoned that if KaiA binds tightly to the KaiB:KaiC-EE497 
complex, HSQC signals would broaden beyond detection because the size of the 
KaiABC complex is > 400 kDa. The HSQC spectra show that there is no binding 
between either KaiA180C or KaiAN129 to the KaiB:KaiC-EE497 complex (Fig. 34). 
However, the HSQC peaks from 15N-KaiA130C disappear in the presence of the 
KaiB:KaiC-EE497 complex (Fig. 34). These spectra collectively indicate that KaiA130C 
binds to the KaiB:KaiC-EE497 complex via the linker region of KaiA. We conclude that 
KaiB inhibits KaiA function during the Dephosphorylation Phase by recruiting KaiA 
away from its original KaiC binding site, the A-loops, through direct interaction with the 
linker region of KaiA.     
Dynamics dominates the Sequential Dephosphorylation Order. KaiC 
dephosphorylates sequentially as follows: pSpT → pST → ST. My goal was to 
determine the basis governing this pattern of dephosphorylation. To test if the rigidity of  
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Figure 34 Mapping of KaiA binding site for KaiCB complex by 1H, 15N-HSQC spectra. 
Titration of KaiA-N (upper two panels), KaiA-130C (middle two panels), and KaiA-
180C (lower two panels) with KaiC-EE497 and KaiB. KaiA-N spans residues 1-129, 
KaiA-130C spans 130-283, and KaiA-180C includes residues 180-283. The structure of S. 
elongatus KaiA (PDB ID 1r8j) on the right is color coded as follows: red (residues 1-131), 
blue (132-180; note that residues 137-146 are missing in crystal structure), and green 
(181-282). The linker of KaiA is colored blue. The molar ratios of KaiA-N, KaiA-180C 
and KaiA-130C vs KaiC-EE497 and KaiB are all 2:2:3. Note that KaiC-EE497 was used 
so that KaiA is unable to bind to KaiC in the absence of KaiB. Sample conditions and 
NMR parameters are described in Table 3. 
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Figure 34 Continued. 
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the CII ring affects the dephosphorylation order, we prepared KaiC-SE (SpT 
phosphomimic) and KaiC-ET (pST phosphomimic) reactions in the presence and 
absence of KaiA and measured the phosphorylation level of KaiC. The purification 
protocols are as described in the materials and methods. The KaiC variants were 
preincubated at 30°C for 16 hour to reach a hypophosphorylated state. Reaction mixtures 
containing 1.2 μM KaiA, 3.5 μM  KaiC variants and 1 mM ATP were incubated for 24h 
at 30°C. The aliquots were collected following the time course as shown in Fig. 20. In 
the presence of KaiA, KaiC-SE phosphorylation increased to 81%, whereas KaiC-ET 
failed to phosphorylate. In the absence of KaiA, the steady state levels of 
phosphosphorylation were 30% and 0% for KaiC-SE and KaiC-ET, respectively. The 
results suggest that the rigidity of the CII ring induced by phospho-S431 inhibits the 
phosphorylation at T432, leading to T432 dephosphorylation first. In contrast, CII ring 
flexibility sustained by phospho-T432 apparently inhibits dephosphorylation of 
phospho-S431. Taken together, the data suggest that CII ring flexibility underpins the 
sequential order of KaiC dephosphorylation. 
    CII-CI interdomain interactions regulate the SasA-initiated output pathway. The 
circadian rhythms of gene expression (46, 59), chromosome compaction (47, 81, 146), 
and cell division gating (51, 147, 148) originate at the Kai oscillator. SasA and RpaA 
constitute a two-component signal transduction pathway that transduces the oscillator 
signal downstream (49, 149). SasA is a histidine protein kinase and RpaA is the cognate 
response regulator. SasA has been shown to interact with KaiC directly (48, 53) but it is 
not clear to which KaiC domain SasA binds, and how the temporal signal from the 
oscillator is transduced to output pathways. To identify the domain of KaiC to which    
SasA binds, we mixed 15N-labeled SasA-N (N-terminal domain of SasA) with either     
isolated CI or CII-EE domains. The purification protocols are as described in the 
materials and methods section. 15N-SasA-N was mixed with unlabeled KaiC-EE, CII-EE, 
and CI at 25°C immediately before collecting HSQC spectra. Experimental detail is 
listed in Table 3. We found that the N-terminal domain of SasA (150) binds to the CI 
ring  but not  to  the  CII  ring of  KaiC, suggesting that output of the oscillator rhythm is  
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Figure 35 1H, 15N-HSQC showing SasA-N (residues 1-107) specifically binds to CI 
monomer. Titration of SasA-N with KaiC-EE (upper two panels), CII-EE (middle 
two panels), and CI (lower two panels). Sample conditions and NMR parameters are 
described in Table 3. 
 
 
  
89
transmitted through the CI ring (Fig. 35). Indeed, the CI ring has an ATPase activity that 
displays a circadian rhythm (62), and this activity gates cell division using a SasA-
dependent pathway (51). Cyanobacterial strains expressing KaiC mutants with high 
ATPase activities, as with the hyperphosphorylated KaiC487 mutant, results in 
elongated non-dividing cells (51). In contrast, cyanobacteria expressing KaiC mutants 
with low ATPase activities, e.g. the KaiC-pSpT phosphomimic (KaiC-DE), undergo 
normal cycles of cell division. Although both KaiC mutants are hyperphosphorylated, 
they have different ATPase activities and produce different cell lengths. Thus, the 
linkage between of ATPase activity and cell length is clear but regulation of the ATPase 
activity has remained mysterious (51). Our data show that the flexibility of CII ring 
regulates the ATPase activity of the CI ring. A flexible CII ring enhances CI ATPase 
activity, whereas a rigid CII ring suppresses CI ATPase activity.  
    Next, we asked how CII-CI interact to regulate the ATPase of the CI ring. There are 
two possibilities: 1) through the peptide linkage joining these two rings, or 2) through 
ring-on-ring stacking. Here, we tested CI-CII ring stacking by mixing isolated CI and 
CII domains followed by gel filtration chromatography. We prepared CII variants and 
isolated CI domains as described in the materials and methods section. The reactions 
were mixed with in a 1:1 monomeric ratio at a concentration of 10 μM in 100 μl at 25 °C 
for 0.5 h. The reactions were then analyzed by a Superdex 200 10/300 GL gel filtration 
column with a flow rate of 0.8 mL/min. As seen in Fig. 36A panel 1-3, the CI ring does 
not interact with CII, CII-SE, or CII-EE domains. However, interactions were observed 
with the hexameric CII-ET domain which has the highest hexamerization level among 
all CII ring variants (Fig. 36A panel 4). Methyl-TROSY spectra of full-length KaiC 
variants show that peaks assignable to the CI domain have chemical shifts and line 
shapes that vary depending on the rigidity of the CII ring (Fig. 36B), thereby 
corroborating the gel filtration data and indicating that CII-CI interactions increase with 
increasing rigidity of the CII ring (Fig. 36, A and B). These observations suggest a 
mechanism by which CII ring rigidity suppresses CI ATPase activity, which is through 
increased ring stacking interactions.  
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Figure 36 CII-CI interactions depend on the state of phosphorylation at residues S431 
and T432.A) Gel-filtration experiments of mixtures of domains of CI with CII (panel 
1) and phosphomimics of CII-SpT (panel 2), CII-pSpT (panel 3), and CII-pST (panel 
4). The hexameric form of the CI and CII domains eluted at ~11.6 mL, whereas the 
monomeric form eluted at ~15.4 mL. The shaded region in panel 4 indicates the shift 
of the CI + pST-CII phosphomimic elution profile relative to those of the domains by 
themselves. B) Selected regions of methyl-TROSY spectra (139)of U-[2H,15N], Ile-
[δ1 13CH3] labeled wt-KaiC (panel 1) and the phosphomimics of KaiC-SpT (panel 2), 
KaiC-pSpT (panel 3), and KaiC-pST (panel 4). All panels were plotted at the same 
relative contour level. Blue resonances are those assigned to the CI domain, whereas 
unassigned peaks are black. Please see Table 3 for experimental details. 
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 4.4 Discussion 
     
     KaiABC complex formation switch KaiC from an autokinase to autophosphatase in 
Dephosphorylation Phase. Qin el al. have suggested that the KaiCB(A) complex 
switches KaiC autokinase to autophosphatase (90). Phospho-S431 is required for the 
formation of the KaiCB(A) complex. The role of KaiB is to inhibit KaiA function. 
Formation of the KaiCB(A) complex using the KaiC489 variant shows that the 
KaiB:KaiC complex creates a new binding site for KaiA, since KaiA’s original binding 
site has been removed in KaiC489. However, how the new binding site is created and 
where it binds KaiA is not clear. In this study, our results provide new information 
regarding these questions. KaiA and KaiB have been shown to interact only weakly in 
 
 
Figure 37 Putative binding site on KaiA on KaiB. KaiB is showed as a dimer form on 
the top (gold) and putative conserved acidic residues involved in binding surface are 
showed as red balls. KaiA is showed in dimer form on the bottom (gray) and putative 
conserved basic resuidues involved in binding surface are showed as blue balls.    
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the absence of KaiC (142), and, therefore it was thought that conformational changes 
either in KaiB or KaiC upon complex formation recruited KaiA away from the A-loops 
(65, 151). We confirmed by NMR (Fig. 34) that a new binding site is created for KaiA 
on KaiB:KaiC complex. Our NMR data further shows that the new binding site is 
created on KaiB (Fig. 30 and 34), which is probably at the interface used to form the 
tetramer observed in free KaiB. Since KaiC does show any conformational change upon 
KaiB binding by NMR, it probably does not participate in direct interactions with KaiA 
during the Dephosphorylation Phase. Strikingly, KaiB undergoes a large conformational 
change, as indicated by NMR. We speculate that the newly created binding site on KaiB 
could be from exposing a hidden interface when KaiB binds to KaiC as a dimer. The 
new binding surface on KaiA has been mapped to the linker region of KaiA (Fig. 34), 
residues 130 to 180. The linker region contains one loop, two α-helixes and one β-sheet. 
Since KaiB is decorated with charged residues, we suspect that the charged residues on 
the α-helix, residues 147-163, of KaiA are directly interact with KaiB. The negatively 
charged C-terminal tail of KaiB is suspected to be the KaiA binding site, as KaiB 
mutants lacking the tail had arrhythmic free-running rhythms. The negatively charged C-
terminal tail of KaiB may interact with the positively charged α-helix on KaiA (Fig. 37). 
However, we can not rule out the alternative possibility from residues 161 – 174, in the 
linker region of KaiA. Upon formation of the KaiABC complex, KaiA can no longer 
bind to the A-loops to stimulate KaiC phosphorylation. At this point, KaiC’s autokinase 
activity is suppressed, allowing its constitutive autophosphatase activity to become the 
dominant activity (152). When KaiC becomes completely dephosphorylated, the CII ring 
regains its flexibility, causing the KaiABC complex to dissociate. KaiB sequesters its 
KaiA binding site by forming tetramers again. KaiA is free to bind to the A-loops again 
to stimulate KaiC phosphorylation, thereby starting a new cycle.   
    CI ATPase activity is regulated by the flexibility of the CII ring. It is insightful to 
speculate on the role of CII ring flexibility in the signal transduction of oscillator signals 
to downstream events. The ATPase activity of the CI ring of KaiC, which displays a 
circadian rhythm (62), applies a cell division checkpoint in cyanobacteria (51). 
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Interestingly, published cell lengths in S. elongatus strains expressing KaiC mutants 
show a strong correlation to our results on CII ring flexibility, with longer lengths 
corresponding to more flexible CII rings, and shorter lengths corresponding to rigid rings. 
ATPase levels of S. elongatus KaiC (51) also correlate with CII ring flexibility, with 
flexible rings correlating to higher ATPase levels. This correlation suggests that 
communication between the CII and CI rings depends on CII ring flexibility. Gel-
filtration data showed that isolated CII-ET domains, which form a hexamer, uniquely 
interact with isolated CI rings (Fig. 36A), allowing us to speculate that a rigid CII ring 
interacts most strongly with the CI ring, and that it is these ring-on-ring contacts that 
suppresses CI ATPase activity. 
   Dong et al. (51) have shown that constitutive phosphorylation of KaiC inhibits cell 
division, however, phosphorylation of KaiC is not essential for cell elongation. Instead, 
it is the elevated ATPase activity of KaiC that inhibits cell division (51). Two 
hyperphosphorylated KaiC mutants, KaiC487 and KaiCE444D, cause elongated cells, 
whereas a hypophosphorylated KaiC mutant, KaiC497, maintains normal cell length. 
However, a fully phosphorylated KaiC mimic, KaiC-DE, does not inhibit cell division, 
whereas KaiC-AA does. These two results seemingly conflict with each other, in which 
two hyperphosphorylated KaiC mutants display opposite cell length phenotypes. Dong et 
al found that it is an elevated ATPase activity of KaiC that causes elongated cell lengths, 
whereas low ATPase activities do not. KaiC487 exhibits high ATPase activity and long 
cells but, in contrast, KaiC-DE exhibits low ATPase activity and normal length cells. It 
could not be explained, however, why the two hyperphosphorylated mutants, KaiC487 
and KaiC-DE, exhibited different cell length phenotypes. Here, our study fills this gap. 
We showed that it is the flexibility of CII ring that controls CI ATPase activity, and CII 
ring flexibility, in turn, is regulated by KaiC phosphorylation A-loop position. KaiC487 
mimics KaiC with the exposed A-loops, which we have  shown to induce flexibility in 
the CII ring. In contrast, KaiC-DE is in a rigid state. The flexible and rigid states 
respectively enhance and inhibit CI ATPase activities by weakening and strengthening 
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CI-CII stacking interactions. Now that we know how KaiC mutants regulate the 
flexibility of the CII ring, we can predict the cell length accurately.  
   SasA and RpaA have been found to be epistatic to KaiC in the control of cell division 
(51). How the temporal signal is transferred from KaiC to SasA-RpaA two component 
regulatory system has been located to the physical interaction between the CI ring of 
KaiC and SasA-N by our data (Fig. 35 and 36). Moreover, the CII-CI ring 
communication has been suggested through chemical linkage (in CHAPTER II and III) 
and ring-on-ring stacking (Fig. 36). Overall, the results lead to the conclusion that CII 
ring rhythmic phosphorylation cycle regulates the flexibility of CII ring. The rhythmic 
flexibility of the CII ring, in turn, governs the cyclic ATPase activity of the CI ring. The 
rhythmic ATPase activity, then, transfers the temporal signal from KaiC to the SasA-
RpaA two component regulatory system ultimately transducing a biochemical rhythm 
into physiological responses such as cell division.           
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CHAPTER V 
CONCLUSION AND FUTURE WORK 
     
This is the first study to reveal that the timing mechanism of the KaiABC oscillator is 
underpinned by KaiC CII ring flexibility (Fig. 38 and 39). The flexibility of the CII ring 
of the KaiC protein governs the sequential pattern of KaiC phosphorylation and 
dephosphorylation, as well as its interaction with KaiA and KaiB. We show that CII-CI 
ring-ring stacking in KaiC also depends on the flexibility of the CII ring, which has 
 
 
 
 
Figure 38 KaiA and KaiB temporally control the ordered phosphorylation of KaiC.  
In the Phosphorylation Phase, CII ring is flexible. KaiA stabilizes the exposed A-loops 
and enhances the phosphorylation at T432 and then S431. Once, KaiC gets fully 
phosphorylated, CII ring becomes rigidity. KaiB binds to the rigid KaiC as a dimer on 
the top of the CII ring. The KaiB:KaiC complex traps KaiA away from its original 
binding site. The KaiCB(A) complex inhibits KaiA function and ensure that KaiC 
dephosphorylates fully.   
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important implications for regulating cell division. These findings are completely 
orthogonal to current attempts at understanding oscillator function, which are all from a 
structural perspective. This study dispels the current notion that functional differences 
between the phosphoforms of KaiC arise from structural differences. Instead, it arises 
from the flexibility of the CII ring. 
CII ring flexibility is required for the Phosphorylation Phase. The flexibility 
destabilizes the buried position of the A-loops of KaiC so that they exist in a dynamic 
equilibrium with an exposed state. KaiA selectively captures the exposed state of the A-
loops, which induces KaiC phosphorylation (85). NMR spectra of the A-loop exposed 
state reveals unique spectral signatures that most likely reflect conformational changes at 
 
 
 
Figure 39 CII ring flexibility governs the circadian rhythm of the cyanobacterial 
oscillator. The vertical direction indicates the flexibility of the CII ring of KaiC, upon 
which depends the extent of CII-CI ring-ring stacking and the dynamic equilibrium of 
the A-loops between their buried and exposed positions (illustrated for free KaiC). The 
ability of the KaiCB complex to sequester KaiA depends on CII ring rigidity.  
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the autokinase site required for activation. The ST and SpT phosphoforms are flexible, 
whereas pSpT is significantly less so. The pST phosphoform in contrast is the least 
flexible. That phosphorylation of T432 precedes that of S431 can now be understood to 
be necessary, because pT disallows pS from quenching CII ring flexibility, which is 
required for A-loop exposure. Hence, the observed pattern of KaiC phosphorylation, ST 
→ SpT → pSpT (65, 66), can now be explained from the standpoint of CII ring 
flexibility. The current work has analyzed the NMR spectra on a qualitative level. The 
next phase of this project is to determine quantitatively the different types of motions in 
the CII ring under different states of phosphorylation by using NMR experiments 
sensitive to ps-ns and μs-ms timescales. 
CII ring flexibility dictates the Transition Phase. An ongoing conundrum has been the 
molecular recognition by KaiB of the pSpT and pST but not of the ST and SpT 
phosphoforms of KaiC. Indeed, the crystal structures of several different KaiC 
phosphoforms are virtually identical (89). Our work here reveals that KaiB binding 
depends on CII ring flexibility, or rather the lack thereof. KaiB binds to pSpT and even 
more rapidly to pST because of phospho-S431 induced rigidity of the CII ring. The lack 
of CII ring rigidity during the Phosphorylation Phase explains why KaiB fails to bind 
prematurely to KaiC. A remaining question is the slow kinetics of KaiB-KaiC binding. 
As observed here and by others, the formation of a stable KaiB:KaiC complex is on the 
order of  hours. Thus, a  future  direction for work on the Transition Phase is to elucidate  
the basis of the slow kinetics of KaiB:KaiC binding. We suspect that the rate 
determining step is the dissociation of KaiB tetramers into dimers. Another important 
goal would be to obtain a higher resolution model of the KaiB:KaiC complex than is 
currently available (87). 
CII ring flexibility dictates the Dephosphorylation Phase. The KaiABC complex 
dephosphorylates as pSpT → pST → ST (65, 66). Upon reaching the ST state, the 
complex dissociates, allowing another cycle to start anew. The stability of the KaiCB(A) 
complex depends critically upon the lack of CII ring flexibility. Hence, phospho-T432 
necessarily dephosphorylates before phospho-S431, so that CII ring rigidity can be 
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maintained until KaiC reaches the ST state. If the order was reversed, pSpT → SpT, the 
KaiABC complex would dissociate prematurely and KaiC would never attain the ST 
state. An important future goal for this project would be to determine the structure of the 
KaiCB(A) complex, especially the KaiB:KaiA binding interface. 
CII ring flexibility regulates clock output signals. The CI ring has been identified as 
the source of clock output signals by two lines of evidence. One is that its ATPase 
activity regulates cell cycle progression (51). The other is that SasA, a clock output 
protein, binds specifically to the CI ring (145). Regulation of its ATPase activity (62) 
such that it displays a circadian rhythm indicates that it must somehow communicate 
with the CII ring, the oscillator part of KaiC. Until now, evidence has been lacking. We 
revealed here that CI-CII ring-ring interactions are enhanced when the CII ring is rigid 
and attenuated when the CII ring is flexible (Fig. 36A). Thus, the circadian rhythms of 
phosphorylation of the CII domain are transmitted to the CI ring through ring-on-ring 
stacking. Increased stacking inhibits the CI ATPase activity, whereas decreased stacking 
relieves the inhibition. An exciting extension of this project would be to determine how 
ring-on-ring stacking affects the structure and dynamics of the CI ring, especially at the 
ATPase active sites. It would also be illuminating to elucidate how stacking affects the 
interaction between the CI ring and SasA, and how these interactions regulate the 
structure and function of SasA. 
Inside the KaiABC oscillator, phospho-S431 plays an important role to ensure the 24 
h rhythm. KaiCB(A) complex formation is initiated when CII ring rigidity is induced by 
phospho-S431. The stable KaiCB(A) complex switches KaiC from the Phosphorylation 
Phase to the Dephosphorylation Phase and from an autokinase to autophosphatase (90). 
On the other hand, phospho-S431 is also suggested to play a role in the temperature 
compensation mechanism (135). Specifically, the particular pST phosphoform sustains 
the 24 h rhythm across the physiological temperature range by regulating the ATPase 
activity of KaiC (135). According to our data, temperature compensation of the ATPase 
activity is linked to CII ring flexibility. Our model, in total, predicts that CII ring 
flexibility/rigidity unifies oscillator and output functions of the Kai system. 
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In conclusion, we present the surprising finding that the flexibility of the CII ring of 
the KaiC protein governs the sequential pattern of KaiC phosphorylation and 
dephosphorylation, as well as its interactions with clock proteins KaiA and KaiB. We 
showed that CII-CI ring-on-ring stacking in KaiC also depends on the flexibility of the 
CII ring, which has important implications for regulating cell division. By revealing that 
all known functions of KaiC originate from the flexibility of its CII ring, we present a 
unifying model. These findings are completely orthogonal to current attempts at 
understanding oscillator function, which are from a structural perspective. Thus, we 
think this work will shake up the field of biological timekeeping, and demonstrates that 
other investigations of this and other clock mechanisms need serious consideration of the 
different dynamic states of clock proteins. 
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APPENDIX A 
DIAGRAMS 
 
A-1. Schematic representation of full-length, fragments or mutants of A) KaiA, B) KaiB, 
C) KaiC, and D) SasA. 
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A-2. Diagram for cloning pET-28b-SUMO-X. 
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A-3. Diagram for cloning pET-28b-SUMO-FLAG-X. 
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A-4. Diagram for cloning pET-28b-SUMO-X-mut by mutation X followed by splicing 
SUMO and X-mut. X-mut stands for mutation of X. 
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A-5. Diagram for cloning pET-28b-SUMO-X-mut by using SUMO-X as template. 
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A-6. Diagram for cloning pET-28b-SUMO-X-mut by using QuickChange method. 
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A-7. Diagram for cloning pTYB1-KaiA-1-129. 
 
 
 
 
 
 
 
 
 
 
 
 
  
126
 
A-8. Diagram for expression of unlabled proteins. LB1 and LB2 differ only in induction 
temperature and time. 
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A-9. Diagram for expression of 15N-labeled proteins. 
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A-10. Diagram for expression of U-[15N, 2H]-Ile-[ δ1 13CH3]- proteins. 
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A-11. Diagram for protein purification with one-step Ni-NTA chromatography. 
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A-12. Diagram for protein purification with two-step Ni-NTA chromatography. 
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APPENDIX B 
SUPPLEMENTARY TABLES 
Table B1. Description of the plotting levels for spectra of KaiC variants for Figure 2. 
 
U-[15N, 2H]-
Ileδ1-[13C, 
1H]-labeled 
proteins 
Concentration 
(μM) (Conc.) 
Number of 
Scan (NS) 
Relative 
signal (Conc. 
x NS) 
Normalized 
signal  
Relative noise 
cut-off 
KaiC-ST 15 128 1920 1.07 1.29E+006 
KaiC-SE 8 256 2048 1.14 1.37E+006 
KaiC-EE 16 128 2048 1.14 1.37E+006 
KaiC-ET 14 128 1792 1.00 1.20E+006 
KaiC-EE487 8 224 1792 1.00 1.20E+006 
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Table B2. Constructs of Thermosynechococcus elongatus kaiA, kaiB,  kaiC and sasA 
 
Construct Cloning sites Resistance Cloning 
Strategy 
kaiA 
pET-28b-SUMO-kaiA NdeI/HindIII Kanamycin Figure S11 
pTYB1-kaiA-1-129 NdeI/SapI Ampicillin Figure S16 
pET-28b-SUMO-kaiA-130-283 NdeI/HindIII Kanamycin Figure S11 
pET-32a-kaiA-180-283 NcoI/BamHI Ampicillin Figure S16 
kaiB 
pET28b-SUMO-AMA-kaiB NdeI/HindIII Kanamycin Figure S11 
kaiC 
pET28b-SUMO-FLAG-kaiC NdeI/HindIII Kanamycin Figure S12 
pET28b-SUMO-FLAG-kaiC-SE NdeI/HindIII Kanamycin Figure S14 
pET28b-SUMO-FLAG-kaiC-EE NdeI/HindIII Kanamycin Figure S14 
pET28b-SUMO-FLAG-kaiC-ET NdeI/HindIII Kanamycin Figure S15 
pET28b-SUMO-FLAG-kaiC-1-487-
EE 
NdeI/HindIII Kanamycin Figure S11 
pET28b-SUMO-FLAG- kaiCI-1-247 NdeI/HindIII Kanamycin Figure S12 
pET28b-SUMO-FLAG-kaiC-CII-
249-518 
NdeI/HindIII Kanamycin Figure S12 
pET28b-SUMO-FLAG-kaiC-CII-
249-518-SE 
NdeI/HindIII Kanamycin Figure S12 
pET28b-SUMO-FLAG-kaiC-CII-
249-518-EE 
NdeI/HindIII Kanamycin Figure S12 
pET28b-SUMO-FLAG-kaiC-CII-
249-518-ET 
NdeI/HindIII Kanamycin Figure S12 
pET28b-SUMO-FLAG-kaiC-CII-
249-487-EE 
NdeI/HindIII Kanamycin Figure S11 
pET28b-SUMO-FLAG-kaiC-CII-
249-487-ET 
NdeI/HindIII Kanamycin Figure S11 
pET28b-SUMO -kaiC-CII-258-518-
S258C-EE-FLAG (short CII-EE) 
NdeI/HindIII Kanamycin Figure S11 
sasA 
pET28b-SUMO-sasA-1-107 NdeI/HindIII Kanamycin Figure S11 
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APPENDIX C 
NMR SAMPLE PREPARATION AND SPECTROSCOPY 
C-1. NMR sample preparation 
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C-2. NMR experiments 
All NMR experiments were performed on a Bruker 600MHz AVANCE III spectrometer 
equipped with a TCI cryoprobe. 1H, 15N-HSQC and 1H-13C methyl-TROSY experiments 
were performed with the following parameters: 
 
1H, 15N-HSQC 
1H:  carrier 4.75 ppm; sweep width of 16.0 ppm; acquisition time: 66.6 ms 
15N: carrier 119.5 ppm; sweep width of 26.5 ppm; acquisition time: 79.4 ms 
 
1H-13C methyl-TROSY 
1H:  carrier -0.71 ppm; sweep width of 6.5 ppm; acquisition time: 63.9 ms 
13C: carrier 13.3 ppm; sweep width of 8.0 ppm; acquisition time: 82.7 ms 
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APPENDIX D 
RECIPE FOR LB AND M9 MEDIA 
LB (1 L) 
10 g Tryptone 
5 g Yeast extract 
10 g NaCl 
Top up to 1 L with ddH2O and autoclave. 
D2O LB (1L) 
10 g Tryptone 
5 g Yeast extract 
10 g NaCl 
Top up to 1 L with 99.8% D2O and filter sterilize using a 0.2 μm membrane (Millipore). 
2xYT (1 L) 
16 g Tryptone 
10 g Yeast extract 
  5 g NaCl 
Top up to 1 L with ddH2O and autoclave. 
LB agar: 
LB medium contains 15 g/L agar. 
For example, add 1.5 g of agar to 100 ml of LB medium. 
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M9 (1L): 
M9 salt solution (1L) 
6.0 g Na2HPO4 
3.0 g KH2PO4 
0.5 g NaCl 
1.0 g 15NH4Cl 
Top up to 1 L with ddH2O and autoclave. 
Other solutions: 
20% D-glucose (20 g/100 ml H2O, filter sterilize) 
1 M MgSO4 (autoclave) 
1 M CaCl2 (autoclave) 
Add the above solutions to 1 L of M9 salt solution to make M9 medium before culturing 
E. coli cells: 
10 ml of 20% D-glucose (final concentration:  2 g/L) 
2 ml of 1 M MgSO4 (final concentration:  2 mM) 
100 μl of 1 M CaCl2 (final concentration:  100 μM) 
antibiotics (Kanamycin final concentration:  
50 μg/ml or Ampicillin final 
concentration 100 μg/ml) 
D2O M9 medium (200 ml) 
We normally make 1L D2O M9 salt solution and filter sterilize the medium using a 0.2 
μm membrane (Millipore). The sterile D2O M9 medium can be stored at room 
temperature for at least three months.  
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M9 salt solution (1L) 
6.0 g Na2HPO4 
3.0 g KH2PO4 
0.5 g NaCl 
1.0 g NH4Cl 
Top up to 1 L with 99.8% D2O (Sigma) and filter sterilize the medium using a 0.2 μm 
membrane. 
Other solutions: 
1 M MgSO4 in 99.8% D2O (filter sterilize) 
1 M CaCl2 in 99.8% D2O (filter sterilize) 
 
Add the above solutions to 200 ml L of M9 salt solution to make M9 medium before 
culturing E. coli cells: 
0.4 g [12C, 2H]-D-gluose (final concentration:  2 g/L) 
1.0 ml BioExpress (10X) (final concentration:  0.5%) 
0.4 ml of 1 M MgSO4 in 99.8% 
D2O 
(final concentration:  2 mM) 
20 μl of 1 M CaCl2 in 99.8% 
D2O 
(final concentration:  100 μM) 
200 μl of 50 mg/ml  Kanamycin 
in 99.8% D2O 
(final concentration:  50 μg 
/ml) 
Note that antibiotics vary depending on the resistance of the plasmid. The final 
concentration of Amp is 100 μg/ml, while that of Kanamycin is 50 μg/ml. 
  
138
APPENDIX E 
ClONING 
 
Cloning of pET-28b-SUMO-X: 
Strategy. PCR amplify SUMO and X gene with their respective sets of primers, 
SUMO_1 primer (5’…GGAGATATACATATGGCTAGCATGTCGGAC…3’) and 
SUMO_2 primer (5’…TCCACCAATCTGTTCTCTGTGAG…3’) for SUMO gene and 
X_1 and X_2 primers for X gene, using the PCR 1 reaction scheme (see section PCR 
reactions and cycles). Load PCR reaction mixtures onto 2% agarose gel and 1.5% (or 
2%, depending on the size) agarose gel, respectively, which is followed by gel extraction 
using standard gel extract protocol provided by the manufacturer (Qiagen). If the band of 
interest is correct and bright on the agarose gels, dilute the purified PCR product by 5 
fold and use as a template. Otherwise, use the purified PCR product as a template 
without dilution.  
 
With the SUMO template and X gene template, carry out a two-step PCR reaction 
scheme (PCR 2 and PCR 3; see section PCR reactions and cycles) to produce the desired 
SUMO-X fragment. The desired fragment was obtained by loading the two-step PCR 
reaction mixture onto 1.5% (or 2%, depending on the size) agarose gel followed by the 
same gel extraction purification protocol mentioned above. SUMO-X fragment was 
digested using NdeI/HindIII endonucleases (New England Biolabs) and purified 
following the PCR purification protocol as described by the manufacturer. The digested 
SUMO-X fragment was ligated into pET-28b which was digested with the same 
endonucleases. Ligated product was used to transform competent BL21 (DE3) E. coli 
cells, which were then plated on LB agar plates supplemented with antibiotics and 
incubated at 37°C overnight. Transformed colonies were PCR screened using SUMO_1 
and X_2 primers in the PCR 4 reaction scheme (see section PCR reactions and cycles). 
Plasmids from positive colonies were extracted using mini-prep plasmid extract kit 
(Qiagen) and submitted for sequencing. 
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See A-2 for protocol. 
 
Cloning of pET-28b-SUMO-FLAG-X: 
Strategy: introduce FLAG coding sequence to the 5’ of X gene and then follow the 
protocol for cloning of pET-28b-SUMO-Y (here Y stands for FLAG-X) 
 
Primer designs: 
Two primers are used to introduce FLAG sequence. X_1 primer, which matches X and 
introduces FLAG, is used to amplify FLAG-X. FLAG primer, which matches FLAG and 
introduces partial SUMO sequence, is used to generate the FLAG-X fragment which will 
be used to generate SUMO-FLAG-X. 
 
The coding sequence for the FLAG (DYKDDDDK) tag is: 5’ … 
GATTACAAGGATGACGAC GATAAG …3’.  
    See A-3 for protocol. 
 
Cloning of pET-28b-SUMO-X-mut 
To make mutations on X gene, three strategies are used. 
(1) Use the two-step PCR reaction scheme (PCR 2 and PCR 3; see section PCR 
reactions and cycles) to produce X-mut and then follow the protocol for cloning 
pET-28b-SUMO-X  For protocol, see A-4. 
(2) PCR amplify SUMO-X1 (X1: the 5’ end of X gene) using SUMO_1 and X_4 primers 
and X2 (X2: the 3’ end of X gene) using X_3 and X_2 primers, and use the products 
as templates to obtain by following the two-step PCR reaction scheme (PCR 2 and 
PCR 3; see section PCR reactions and cycles) SUMO-X-mut fragment using 
SUMO_1 and X_2 primers. For protocol, see A-5. 
(3) QuickChange. For protocol, see A-6. 
 
Cloning of pTYB1-X gene: 
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X gene was PCR amplified, and sequentially digested by NdeI and Sap I endonucleases 
(New England Biolabs). The digested mixture was then purified using PCR purification 
kit (Qiagen). The purified X gene was then ligated into pTYB1 which was also digested 
using Nde I/SapI endonucleases (New England Biolabs) sequentially. For protocol, see 
A-7. 
 
Preparation of competent BL21 (DE3) E. coli cells 
 
This method requires the following reagents: 
 
200 ml LB medium (autoclaved) 
0.1 M CaCl2 (autoclaved) 
50 ml centrifuge tubes (sterile) 
80% glycerol (autoclaved) 
1.5 ml tubes (autoclaved) 
 
Make competent cells from 200 ml culture 
 
(01)  inoculate 5 ml of LB medium with BL21(DE3) E. coli cells (Invitrogen) 
(02)  grow at 37°C and 220 rpm overnight 
(03)  transfer the overnight culture into 200 ml LB medium 
(04)  grow at 37°C and 220 rpm until OD600 reaches 0.8-1.0 
(05)  put the culture on ice for at least 30 min 
(06)  spin down the chilled cell culture at 4°C for 10 min 
(07)  resuspend cell pellet with 10 ml pre-chilled 0.1 M CaCl2 solution 
(08)  leave on ice for at least 30 min 
(09)  spin down at 4,000 rpm for 10 min 
(10)  resuspend with 4 ml of 0.1 M CaCl2, add 1 ml of 80% glycerol, and mix thoroughly 
(11)  aliquot (100 μl each tube) and store at -80°C 
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PCR reactions and cycles 
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Digestion 
                
 
Ligation 
 
A typical ligation reaction is as follows: 
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Transformation 
 
(1) take out a tube of competent cells (100 μl) and thaw on ice for about 30 min 
(2) add ligation mixture (~10 μl) into the above competent cells and incubate on ice for 
30 min. [At this time, set the water bath to 42°C] 
(3) heat shock at 42°C for 45 s 
(4) incubate on ice for 3 min 
(5) add 600 μl of 2xYT medium and shake at 220 rpm and 37 °C for 1 h 
(6) spin down at 5,000 rpm for 2 min 
(7) remove medium so that the remaining volume is about 100 μl 
(8) resuspend cell pellet with the residual medium 
(9) plate on LB agar plate and incubate at 37°C overnight 
 
PCR screening 
 
(1) pick up 2-4 colonies and inoculate 1 ml LB medium with appropriate antibiotics 
(2) grow at 37°C and 220 rpm for about 4 h (OD600 about 0.4) 
(3) take 0.4 μl as template for PCR screening using the PCR 4 reaction scheme (see 
section PCR reactions and cycles). Note the reaction volume is 20 μl. 
(4) for positive colonies (two is enough in most cases), add additional 4 ml LB medium 
with appropriate antibiotics into the tubes 
(5) next morning, save 1 ml as glycerol stock and the rest is used for extraction of 
plasmid 
(6) extracted plasmids are submitted for sequencing 
 
Construct of KaiA, KaiB, KaiC, and SasA  
See Appendix B. 
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APPENDIX F 
PROTEIN EXPRESSION 
 
General Strategy 
 
Expression of unlabeled proteins 
 
The plasmid encoding the gene of interest was transformed into BL21 (DE3) E. coli cells. 
Cells harboring the plasmid (or such glycerol stocks) were grown in LB medium 
supplemented with appropriate antibiotics (Kanamycin final concentration: 50 μg/ml and 
Ampicillin final concentration: 100 μg/ml) at 37°C until an OD600 of ~0.6. Protein 
expression was induced by adding IPTG to a final concentration of 0.2 mM. Protein 
induction period is about 4 h at 37°C or 12 h at 25°C. See appendix A-8 for detail. 
 
Expression of 15N-labeled proteins 
 
The plasmid encoding the gene of interest was transformed into BL21 (DE3) E. coli cells. 
Cells harboring the plasmid (or such glycerol stocks) were grown in M9 (H2O) minimal 
medium supplemented with appropriate antibiotics (Kanamycin final concentration: 50 
μg/ml and Ampicillin final concentration: 100 μg/ml) at 37°C until an OD600 of ~0.6. 
Note that M9 minimal medium contains 15N-NH4Cl and D-glucose as the sole nitrogen 
and carbon resource, respectively. Protein expression was induced by adding IPTG to a 
final concentration of 0.2 mM. Protein induction period is about 12 h at 25°C. See A-9 
for detail. Note that M9 minimal medium contains 15N-NH4Cl and fully deuterated D-
glucose as the sole nitrogen and carbon resource, respectively, and BioExpress 
(Cambridge Isotope Laboratories) was used to increase the growth rate of E. coli.  
 
 
Expression of U-[15N, 2H], Ileδ1-[13C,1H] proteins 
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The plasmid encoding the gene of interest was transformed into BL21 (DE3) E. coli cells. 
Cells harboring the plasmid (or such glycerol stocks) were grown in M9 (D2O) minimal 
medium supplemented with Kanamycin at a final concentration of 50 μg/ml at 37°C and 
220 rpm until an OD600 of 0.4-0.5. Αlpha-ketobutyric acid-4-13C,3,3-d2 sodium salt 
hydrate (Sigma) was added and cultures continued to grow at 37°C and 220 rpm for an 
hour. Protein expression was induced by adding IPTG (stock in D2O) to a final 
concentration of 0.2 mM. Protein induction period is about 12 h at 25°C. See appendix 
A-10 for detail. Note that M9 minimal medium contains 15N-NH4Cl and fully deuterated 
D-glucose as the sole nitrogen and carbon resource, respectively, and BioExpress 
(Cambridge Isotope Laboratories) was used to increase the growth rate of E. coli.  
 
Expression and Purification of Ulp1, KaiA, KaiB, KaiC, and SasA 
 
Ulp1 
 
Unlabeled Ulp1 
Expression: Follow protocol A-8. 
Purification: Follow protocol A-12 but stops after the elution step of 1st Ni-NTA column. 
 
Purification: 
Lysis: 
(Cell pellet from 1 L culture is resuspended in 30 ml of Lysis Buffer) 
Lysis Buffer: 50 mM NaH2PO4, 500 mM NaCl, pH 8.0 
Ni Column: 
Wash Buffer: 50 mM NaH2PO4, 500 mM NaCl, 20 mM imidazole, pH 8.0 
Elution Buffer: 50 mM NaH2PO4, 500 mM NaCl, 250 mM imidazole, pH 8.0 
 
Note that Ulp1 is not stable in buffers where NaCl is at a concentration lower than 100 
mM.For long-term storage, add equal volume of glycerol into the Ulp1 elution sample 
from Ni-NTA column and store at -80°C. Ulp1 elution sample can be diluted to a final 
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concentration of 200 μM before adding glycerol. Therefore, the final Ulp1 stock (stored 
at -80°C) will be 100 μM in the buffer of 25 mM NaH2PO4, 250 mM NaCl, 125 mM 
imidazole, 50% glycerol, pH 8.0. 
 
KaiA 
 
Unlabeled KaiA 
Expression: Follow protocol A-8 
Purification: Follow protocol A-12 
 
N15-labeled KaiA-130-283 
Expression: Follow protocol A-9 
Purification: Follow protocol A-12 
 
Purification 
Lysis: 
(Cell pellet from 1 L culture is resuspended in 30 ml of Lysis Buffer) 
Lysis Buffer: 50 mM NaH2PO4, 500 mM NaCl, pH 8.0 
1st Ni Column: 
Wash Buffer: 50 mM NaH2PO4, 500 mM NaCl, 20 mM imidazole, pH 8.0 
Elution Buffer: 50 mM NaH2PO4, 500 mM NaCl, 250 mM imidazole, pH 8.0 
Desalting: 
Desalting Buffer: 20 mM Tris, 50 mM NaCl, 20 mM imidazole, pH 8.0 
2nd Ni Column: 
Equilibration Buffer: the same as Desalting Buffer 
Superdex 75: 
Equilibration Buffer: 20 mM Tris, 50 mM NaCl, 1mM MgCl2, 5 mM DTT, 1mM 
ATP, pH 7.0 
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N15-labeled KaiA-1-129 (KaiA-N129) 
Expression: Follow protocol A-9 
Purification: protocol described as follows 
 
Purification  
Lysis: 
(Cell pellet from 1 L culture is resuspended in 30 ml of Lysis Buffer) 
Lysis Buffer: 20 mM Tris, 500 mM NaCl, 1 mM EDTA, pH 8.0 
Chitin Column: 
Wash Buffer: 20 mM Tris, 500 mM NaCl, 1 mM EDTA, pH 8.0 
Cleavage Buffer: 20 mM Tris, 500 mM NaCl, 100 mM MENSA (sodium 2-
mercaptoethanesulfonate; MP Biomedicals), 1 mM EDTA, pH 8.0 
(The cleavage is carried out at 4°C for overnight.) 
Elution Buffer: the same as Cleavage Buffer 
Desalting: 
Desalting Buffer: 20 mM Tris, 50 mM NaCl, 1mM MgCl2, 5 mM DTT, 1mM 
ATP, pH 7.0 
 
N15-labeled KaiA-180-283 
Expression: Follow protocol A-9  
Purification: protocol described as follows 
(The Trx fusion protein Trx-KaiA-180-283 (KaiA-C180) is cleavage by enterokinase.) 
 
Lysis: 
(Cell pellet from 1 L culture is resuspended in 30 ml of Lysis Buffer) 
Lysis Buffer: 50 mM Tris, 500 mM NaCl, pH 7.0 
1st Ni Column: 
Wash Buffer: 50 mM Tris, 500 mM NaCl, 20 mM imidazole, pH 7.0 
Elution Buffer: 50 mM Tris, 500 mM NaCl, 250 mM imidazole, pH 7.0 
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1st Desalting: 
Desalting Buffer: 20 mM Tris, 20 mM NaCl, pH 7.0 
HP Q column: 
Low Salt Buffer: 20 mM Tris, 20 mM NaCl, pH 7.0 
High Salt Buffer: 20 mM Tris, 1 M NaCl, pH 7.0 
2nd Desalting: 
Cleavage Buffer: 20 mM Tris, 50 mM NaCl, 2 mM CaCl2, pH 7.0 
Enterokinase (EMD Chemicals) is added to a final concentration of 1 Unit/ml 
and NaN3 is added to a final concentration of 0.02%. The cleavage is carried out 
at room temperature for overnight. If the cleavage is not complete, more protease 
will be added for extended cleavage.  
2nd Ni Column: 
Elution Buffer: 50 mM Tris, 500 mM NaCl, pH 7.0  
2nd Desalting: 
Desalting Buffer: 20 mM Tris, 50 mM NaCl, 1mM MgCl2, 5 mM DTT, 1mM 
ATP, pH 7.0 
 
KaiB 
 
Unlabeled AMA-KaiB 
Expression: Follow protocol A-8 
Purification: Follow protocol A-12 
 
U-[15N, 2H], Ileδ1-[13C,1H]-KaiB 
Expression: Follow protocol A-10 
Purification: Follow protocol A-12 
 
Purification: 
Lysis: 
  
149
(Cell pellet from 1 L culture is resuspended in 30 ml of Lysis Buffer) 
Lysis Buffer: 50 mM NaH2PO4, 500 mM NaCl, pH 8.0 
1st Ni Column: 
Wash Buffer: 50 mM NaH2PO4, 500 mM NaCl, 20 mM imidazole, pH 8.0 
Elution Buffer: 50 mM NaH2PO4, 500 mM NaCl, 250 mM imidazole, pH 8.0 
Desalting: 
Desalting Buffer: 20 mM Tris, 50 mM NaCl, 20 mM imidazole, pH 8.0 
2nd Ni Column: 
Equilibration Buffer: the same as Desalting Buffer 
Superdex 75: 
Equilibration Buffer: 20 mM Tris, 50 mM NaCl, 1mM MgCl2, 5 mM DTT, 1mM 
ATP, pH 7.0 
 
KaiC 
Unlabeled KaiC KaiC, KaiC-SE, KaiC-EE, KaiC-ET, KaiC-EE487, and KaiC-EE497) 
Expression: Follow protocol A-8 
Purification: Follow protocol A-11 
 
U-[15N, 2H], Ileδ1-[13C,1H]-KaiC (KaiC, KaiC-SE, KaiC-EE, KaiC-ET, KaiC-EE487) 
Expression: Follow protocol A-10 
Purification: Follow protocol A-11 
 
Purification: 
Lysis: 
(Cell pellet from 1 L culture is resuspended in 30 ml of Lysis Buffer) 
Lysis Buffer: 50 mM NaH2PO4, 500 mM NaCl, 1 mM ATP, pH 8.0 
1st Ni Column: 
Wash Buffer: 50 mM NaH2PO4, 500 mM NaCl, 20 mM imidazole, 1 mM ATP, 
pH 8.0 
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Elution Buffer: 50 mM NaH2PO4, 500 mM NaCl, 250 mM imidazole, 1 mM 
ATP, pH 8.0 
Desalting: 
Desalting Buffer: 20 mM Tris, 50 mM NaCl, 20 mM imidazole, 1 mM ATP, pH 
8.0 
2nd Ni Column: 
Equilibration Buffer: the same as Desalting Buffer 
Superdex 200: 
Equilibration Buffer: 20 mM Tris, 50 mM NaCl, 1mM MgCl2, 5 mM DTT, 1mM 
ATP, pH 7.0 
 
KaiC-CI 
 
Unlabeled KaiC-CI 
Expression: Follow protocol A-8 
Purification: Follow protocol A-12 
 
U-[15N, 2H], Ileδ1-[13C,1H]-KaiC-CI 
Expression: Follow protocol A-10 
Purification: Follow protocol A-12 
 
Purification: 
Lysis: 
(Cell pellet from 1 L culture is resuspended in 30 ml of Lysis Buffer) 
Lysis Buffer: 50 mM NaH2PO4, 500 mM NaCl, pH 8.0 
1st Ni Column: 
Wash Buffer: 50 mM NaH2PO4, 500 mM NaCl, 20 mM imidazole, pH 8.0 
Elution Buffer: 50 mM NaH2PO4, 500 mM NaCl, 250 mM imidazole, pH 8.0 
Desalting: 
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Desalting Buffer: 20 mM Tris, 50 mM NaCl, 20 mM imidazole, pH 8.0 
2nd Ni Column: 
Equilibration Buffer: the same as Desalting Buffer 
Superdex 75: 
Equilibration Buffer: 20 mM Tris, 50 mM NaCl, 1mM MgCl2, 5 mM DTT, pH 
7.0 
 
KaiC-CII 
 
Unlabeled KaiC-CII (CII, CII-SE, CII-EE, CII-ET, CII-EE, CII-ET, short CII-EE) 
Expression: Follow protocol A-8 
Purification: Follow protocol A-12 
 
U-[15N, 2H], Ileδ1-[13C,1H]-KaiC-CII-249-518-EE: 
Expression: Follow protocol on A-10 
Purification: Follow protocol on A-12 
 
Purification: 
Lysis: 
(Cell pellet from 1 L culture is resuspended in 30 ml of Lysis Buffer) 
Lysis Buffer: 50 mM NaH2PO4, 500 mM NaCl, pH 8.0 
1st Ni Column: 
Wash Buffer: 50 mM NaH2PO4, 500 mM NaCl, 20 mM imidazole, pH 8.0 
Elution Buffer: 50 mM NaH2PO4, 500 mM NaCl, 250 mM imidazole, pH 8.0 
Desalting: 
Desalting Buffer: 20 mM Tris, 50 mM NaCl, 20 mM imidazole, pH 8.0 
2nd Ni Column: 
Equilibration Buffer: the same as Desalting Buffer 
Superdex 75: 
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Equilibration Buffer: 20 mM Tris, 50 mM NaCl, 1mM MgCl2, 5 mM DTT, pH 
7.0 
 
SasA-N 
 
N15-labeled SasA-N 
Expression: Follow protocol on A-9 
Purification: Follow protocol on A-12 
 
Purification: 
Lysis: 
(Cell pellet from 1 L culture is resuspended in 30 ml of Lysis Buffer) 
Lysis Buffer: 50 mM NaH2PO4, 500 mM NaCl, pH 8.0 
1st Ni Column: 
Wash Buffer: 50 mM NaH2PO4, 500 mM NaCl, 20 mM imidazole, pH 8.0 
Elution Buffer: 50 mM NaH2PO4, 500 mM NaCl, 250 mM imidazole, pH 8.0 
Desalting: 
Desalting Buffer: 20 mM Tris, 50 mM NaCl, 20 mM imidazole, pH 8.0 
2nd Ni Column: 
Equilibration Buffer: the same as Desalting Buffer 
Superdex 75: 
Equilibration Buffer: 20 mM Tris, 50 mM NaCl, 1mM MgCl2, 5 mM DTT, pH 
7.0 
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